a260_a280_ratio,aa_change,adapter_content,adapter_name,adapter_sequence,additional_pathology_findings,adrenal_hormone,adverse_event,adverse_event_grade,age_at_diagnosis,age_at_index,age_at_last_exposure,age_at_onset,age_is_obfuscated,aggregated_somatic_mutations,aids_risk_factors,ajcc_clinical_m,ajcc_clinical_n,ajcc_clinical_stage,ajcc_clinical_t,ajcc_pathologic_m,ajcc_pathologic_n,ajcc_pathologic_stage,ajcc_pathologic_t,ajcc_staging_system_edition,alcohol_days_per_week,alcohol_drinks_per_day,alcohol_frequency,alcohol_history,alcohol_intensity,alcohol_type,aligned_reads_files,aligned_reads_indexes,alignment_cocleaning_workflows,alignment_workflows,aliquot_quantity,aliquot_volume,aliquots,amount,analysis_metadata_files,analyte_quantity,analyte_type,analyte_type_id,analyte_volume,analytes,anaplasia_present,anaplasia_present_type,aneuploidy,ann_arbor_b_symptoms,ann_arbor_b_symptoms_described,ann_arbor_clinical_stage,ann_arbor_extranodal_involvement,ann_arbor_pathologic_stage,annotated_somatic_mutations,antigen,archives,asbestos_exposure,asbestos_exposure_type,average_base_quality,average_insert_size,average_read_length,awg_review,barretts_esophagus_goblet_cells_present,base_caller_name,base_caller_version,basic_statistics,batch_id,bcr_id,best_overall_response,biospecimen_anatomic_site,biospecimen_laterality,biospecimen_supplements,biospecimen_type,biospecimen_volume,blood_test_normal_range_lower,blood_test_normal_range_upper,bmi,body_surface_area,bone_marrow_malignant_cells,breslow_thickness,burkitt_lymphoma_clinical_variant,cancer_detection_method,cases,catalog_reference,category,cause_of_death,cause_of_death_source,cause_of_response,cd4_count,cdc_hiv_risk_factors,cell_count,center_type,centers,channel,chemical_exposure_type,chemo_concurrent_to_radiation,child_pugh_classification,chip_id,chip_position,chipseq_antibody,chipseq_target,chromosomal_translocation,chromosome,chromosome_arm,cigarettes_per_day,circumferential_resection_margin,clark_level,classification,classification_of_tumor,clinical_supplements,clinical_trial_indicator,clonality,coal_dust_exposure,code,cog_liver_stage,cog_neuroblastoma_risk_group,cog_renal_stage,cog_rhabdomyosarcoma_risk_group,columnar_mucosa_present,comorbidities,comorbidity,comorbidity_method_of_diagnosis,composition,concentration,consent_type,consistent_pathology_review,contamination,contamination_error,contiguous_organ_invaded,copy_number,copy_number_auxiliary_files,copy_number_estimates,copy_number_liftover_workflows,copy_number_segments,copy_number_variation_workflows,country_of_birth,country_of_residence_at_enrollment,course_number,created_datetime,creation_datetime,creator,current_weight,cytoband,data_category,data_format,data_formats,data_subtypes,data_type,data_types,days_to_adverse_event,days_to_best_overall_response,days_to_birth,days_to_collection,days_to_comorbidity,days_to_consent,days_to_death,days_to_diagnosis,days_to_first_event,days_to_follow_up,days_to_imaging,days_to_last_follow_up,days_to_last_known_disease_status,days_to_lost_to_followup,days_to_pathology_detail,days_to_progression,days_to_progression_free,days_to_recurrence,days_to_risk_factor,days_to_sample_procurement,days_to_sequencing,days_to_test,days_to_treatment_end,days_to_treatment_start,dbgap_accession_number,demographics,derived_files,described_cases,diabetes_treatment_type,diagnoses,diagnosis_is_primary_disease,diagnosis_pathologically_confirmed,discontiguous_lesion_count,disease_response,disease_type,distance_normal_to_tumor,distributor_reference,dlco_ref_predictive_percent,doi,double_expressor_lymphoma,double_hit_lymphoma,drug_category,dysplasia_degree,dysplasia_type,ecog_performance_status,education_level,eln_risk_classification,embolic_agent,encoding,enneking_msts_grade,enneking_msts_metastasis,enneking_msts_stage,enneking_msts_tumor_site,ensat_clinical_m,ensat_pathologic_n,ensat_pathologic_stage,ensat_pathologic_t,environmental_tobacco_smoke_exposure,epithelioid_cell_percent,error_type,esophageal_columnar_dysplasia_degree,esophageal_columnar_metaplasia_present,ethnicity,evidence_of_progression_type,evidence_of_recurrence_type,exercise_frequency_weekly,exon,experiment_metadata_files,experiment_name,experimental_protocol_type,experimental_strategies,experimental_strategy,exposure_duration,exposure_duration_hrs_per_day,exposure_duration_years,exposure_source,exposure_type,exposures,expression_analysis_workflows,extracapsular_extension,extracapsular_extension_present,extranodal_extension,extrascleral_extension,extrathyroid_extension,eye_color,fab_morphology_code,family_histories,fastq_name,fev1_fvc_post_bronch_percent,fev1_fvc_pre_bronch_percent,fev1_ref_post_bronch_percent,fev1_ref_pre_bronch_percent,figo_stage,figo_staging_edition_year,file_name,file_size,file_state,files,filtered_copy_number_segments,first_event,first_symptom_longest_duration,first_symptom_prior_to_diagnosis,flow_cell_barcode,follow_ups,fragment_maximum_length,fragment_mean_length,fragment_minimum_length,fragment_standard_deviation_length,fragmentation_enzyme,freezing_method,gastric_esophageal_junction_involvement,gender,gene_expressions,gene_symbol,genomic_profile_harmonization_workflows,germline_mutation_calling_workflows,gleason_grade_group,gleason_grade_tertiary,gleason_patterns_percent,gleason_score,goblet_cells_columnar_mucosa_present,greatest_tumor_dimension,gross_tumor_weight,growth_rate,haart_treatment_indicator,height,hepatitis_sustained_virological_response,histologic_progression_type,histone_family,histone_variant,history_of_tumor,history_of_tumor_type,hiv_viral_load,hormonal_contraceptive_type,hormonal_contraceptive_use,hormone_replacement_therapy_type,hpv_positive_type,hpv_strain,hysterectomy_margins_involved,hysterectomy_type,icd_10,icd_10_code,id,igcccg_stage,imaging_anatomic_site,imaging_date,imaging_findings,imaging_result,imaging_suv,imaging_suv_max,imaging_type,immunosuppressive_treatment_type,in_review,includes_spike_ins,index_date,initial_disease_status,initial_weight,inpc_grade,inpc_histologic_group,inrg_stage,inss_stage,instrument_model,intended_release_date,intermediate_dimension,international_prognostic_index,intron,irs_group,irs_stage,is_ffpe,is_legacy,ishak_fibrosis_score,iss_stage,karnofsky_performance_status,kmer_content,laboratory_test,lane_number,largest_extrapelvic_peritoneal_focus,last_known_disease_status,laterality,legacy_created_datetime,legacy_updated_datetime,lesions_treated_number,library_name,library_preparation_kit_catalog_number,library_preparation_kit_name,library_preparation_kit_vendor,library_preparation_kit_version,library_selection,library_strand,library_strategy,loci_abnormal_count,loci_count,locus,longest_dimension,lost_to_followup,lymph_node_dissection_method,lymph_node_dissection_site,lymph_node_involved_site,lymph_node_involvement,lymph_nodes_positive,lymph_nodes_removed,lymph_nodes_tested,lymphatic_invasion_present,magnification,major_version,margin_distance,margin_status,margins_involved_site,marital_status,masaoka_stage,masked_methylation_arrays,masked_somatic_mutations,max_tumor_bulk_site,md5sum,mean_coverage,measurement_type,measurement_unit,medulloblastoma_molecular_classification,melanoma_known_primary,menopause_status,metaplasia_present,metastasis_at_diagnosis,metastasis_at_diagnosis_site,method_of_diagnosis,method_of_sample_procurement,methylation_array_harmonization_workflows,methylation_beta_values,methylation_liftover_workflows,micrometastasis_present,micropapillary_features,minor_version,mirna_expression_workflows,mirna_expressions,mismatch_repair_mutation,mitosis_karyorrhexis_index,mitotic_count,mitotic_total_area,molecular_analysis_method,molecular_consequence,molecular_tests,morphologic_architectural_pattern,morphology,msi_score,msi_status,multiplex_barcode,mutation_codon,myasthenia_gravis_classification,nadir_cd4_count,name,namespace,necrosis_percent,necrosis_present,no_matched_normal_low_pass_wgs,no_matched_normal_targeted_sequencing,no_matched_normal_wgs,no_matched_normal_wxs,non_nodal_regional_disease,non_nodal_tumor_deposits,nononcologic_therapeutic_agents,normal_tumor_genotype_snp_match,notes,number_expect_cells,number_of_cycles,number_of_fractions,number_proliferating_cells,occupation_duration_years,occupation_type,oct_embedded,other_clinical_attributes,ovarian_specimen_status,ovarian_surface_involvement,overrepresented_sequences,oxygen_use_indicator,oxygen_use_type,pack_years_smoked,pairs_on_diff_chr,pancreatitis_onset_year,papillary_renal_cell_type,parent_samples,parent_with_radiation_exposure,passage_count,pathogenicity,pathology_details,pathology_report_uuid,pathology_reports,pediatric_kidney_staging,per_base_n_content,per_base_sequence_content,per_base_sequence_quality,per_sequence_gc_content,per_sequence_quality_score,per_tile_sequence_quality,percent_eosinophil_infiltration,percent_follicular_component,percent_gc_content,percent_granulocyte_infiltration,percent_inflam_infiltration,percent_lymphocyte_infiltration,percent_monocyte_infiltration,percent_necrosis,percent_neutrophil_infiltration,percent_normal_cells,percent_rhabdoid_features,percent_sarcomatoid_features,percent_stromal_cells,percent_tumor_cells,percent_tumor_invasion,percent_tumor_nuclei,perineural_invasion_present,peripancreatic_lymph_nodes_positive,peripancreatic_lymph_nodes_tested,peritoneal_fluid_cytological_status,peritoneal_washing_results,plate_name,plate_well,platform,platforms,ploidy,pmid,portion_number,portions,pregnancy_count,pregnancy_outcome,pregnant_at_diagnosis,premature_at_birth,prescribed_dose,preservation_method,primary_diagnosis,primary_disease,primary_gleason_grade,primary_site,prior_malignancy,prior_treatment,proc_internal,procedures_performed,programs,progression_or_recurrence,progression_or_recurrence_anatomic_site,progression_or_recurrence_type,project,project_id,projects,proportion_base_mismatch,proportion_coverage_10x,proportion_coverage_30x,proportion_reads_duplicated,proportion_reads_mapped,proportion_targets_no_coverage,prostatic_chips_positive_count,prostatic_chips_total_count,prostatic_involvement_percent,protein_expressions,protocol_identifier,race,radiosensitizing_agent,radon_exposure,raw_methylation_arrays,read_group_name,read_group_qcs,read_groups,read_length,read_pair_number,reason_treatment_ended,reason_treatment_not_given,recist_targeted_regions_number,recist_targeted_regions_sum,reflux_treatment_type,regimen_or_line_of_therapy,related_files,related_to_files,relationship_age_at_diagnosis,relationship_gender,relationship_primary_diagnosis,relationship_type,relative_deceased,relative_smoker,relative_with_cancer_history,relatives_with_cancer_history_count,releasable,release_date,release_requested,released,request_submission,residual_disease,residual_tumor,residual_tumor_measurement,respirable_crystalline_silica_exposure,revision,rhabdoid_percent,rhabdoid_present,ribosomal_rna_28s_16s_ratio,rin,risk_factor,risk_factor_method_of_diagnosis,risk_factor_treatment,risk_factors,rna_expression_workflows,rna_integrity_number,roots,route_of_administration,run_metadata_files,sample_ordinal,sample_type,sample_type_id,samples,sarcomatoid_percent,sarcomatoid_present,satellite_nodule_present,scan_tracer_used,schema_version,second_exon,second_gene_symbol,secondary_expression_analyses,secondary_gleason_grade,secondhand_smoke_as_child,section_location,selected_normal_low_pass_wgs,selected_normal_targeted_sequencing,selected_normal_wgs,selected_normal_wxs,sequence_duplication_levels,sequence_length_distribution,sequencing_center,sequencing_date,short_name,shortest_dimension,simple_germline_variations,simple_somatic_mutations,single_cell_library,site_of_resection_or_biopsy,sites_of_involvement,sites_of_involvement_count,size_extraocular_nodule,size_selection_range,slide_images,slides,smoking_frequency,somatic_aggregation_workflows,somatic_annotation_workflows,somatic_copy_number_workflows,somatic_mutation_calling_workflows,somatic_mutation_indexes,specialized_molecular_test,specimen_type,spectrophotometer_method,spike_ins_concentration,spike_ins_fasta,spindle_cell_percent,stain_type,staining_intensity_scale,staining_intensity_value,state,state_comment,status,structural_variant_calling_workflows,structural_variations,submission_enabled,submitted_aligned_reads_files,submitted_genomic_profiles,submitted_genotyping_arrays,submitted_methylation_beta_values,submitted_tangent_copy_numbers,submitted_unaligned_reads_files,submitter_id,supratentorial_localization,synchronous_malignancy,tags,target_capture_kit,target_capture_kit_catalog_number,target_capture_kit_name,target_capture_kit_target_region,target_capture_kit_vendor,target_capture_kit_version,test_analyte_type,test_result,test_units,test_value,test_value_range,therapeutic_agents,therapeutic_level_achieved,therapeutic_levels_achieved,therapeutic_target_level,time_between_clamping_and_freezing,time_between_excision_and_freezing,time_between_waking_and_first_smoke,timepoint_category,tissue_collection_type,tissue_microarray_coordinates,tissue_or_organ_of_origin,tissue_source_sites,tissue_type,to_trim_adapter_sequence,tobacco_smoking_onset_year,tobacco_smoking_quit_year,tobacco_smoking_status,total_reads,total_sequences,transcript,transglottic_extension,treatment_anatomic_site,treatment_anatomic_sites,treatment_arm,treatment_dose,treatment_dose_max,treatment_dose_units,treatment_duration,treatment_effect,treatment_effect_indicator,treatment_frequency,treatment_intent_type,treatment_or_therapy,treatment_outcome,treatment_outcome_duration,treatment_type,treatments,tumor_burden,tumor_code,tumor_code_id,tumor_confined_to_organ_of_origin,tumor_depth,tumor_depth_descriptor,tumor_depth_measurement,tumor_descriptor,tumor_focality,tumor_grade,tumor_grade_category,tumor_infiltrating_lymphocytes,tumor_infiltrating_macrophages,tumor_largest_dimension_diameter,tumor_length_measurement,tumor_level_prostate,tumor_ploidy,tumor_purity,tumor_regression_grade,tumor_shape,tumor_thickness,tumor_width_measurement,type,type_of_smoke_exposure,type_of_tobacco_used,uicc_clinical_m,uicc_clinical_n,uicc_clinical_stage,uicc_clinical_t,uicc_pathologic_m,uicc_pathologic_n,uicc_pathologic_stage,uicc_pathologic_t,uicc_staging_system_edition,ulceration_indicator,undescended_testis_corrected,undescended_testis_corrected_age,undescended_testis_corrected_laterality,undescended_testis_corrected_method,undescended_testis_history,undescended_testis_history_laterality,updated_datetime,use_per_day,variant_origin,variant_type,vascular_invasion_present,vascular_invasion_type,viral_hepatitis_serologies,vital_status,weeks_gestation_at_birth,weight,weiss_assessment_findings,weiss_assessment_score,well_number,wgs_coverage,who_cns_grade,who_nte_grade,wilms_tumor_histologic_subtype,workflow_end_datetime,workflow_link,workflow_start_datetime,workflow_type,workflow_version,year_of_birth,year_of_death,year_of_diagnosis,year_of_follow_up,years_smoked,zone_of_origin_prostate,zygosity
1.85,V600E,FAIL,Illumina_Universal_Adapter,AGATCGGAAGAGCACACGTCTGAACTCCAGTCA,Asbestos bodies,No,Diarrhea,Grade 1,7305,1,18,5,True,TP53 mutations,Coccidioidomycosis,M0,N0 (i+),Stage 0,T1b,M0,N0 (mol-),Not Reported,T1,1st,0.0,0.0,Daily Drinker,No,Drinker,Beer,tumor_sample_01.bam,R1_23456,1. Sequence Alignment Optimization,BWA-MEM,50,50,Tumor biopsy frozen,0.5,gene_expression_summary.csv,2.5,DNA,D,50,BRCA1,No,Absent,Monosomy,No,Fever,Not Reported,No,Not Reported,KRAS_G12D,CD14,The Cancer Genome Atlas (TCGA),No,Amosite,35.2,150,75,True,No,Illumina BaseSpace,Guppy_4.0.11,FAIL,101,BCR-AB01,AJ-Adjuvant Therapy,Back,Bilateral,Fetal Bovine Serum,Bone Marrow,1.5,4.5,10.5,18.5,1.52,No,0.5,Endemic,Not Reported,Breast cancer,HCMI-00123,BCR Notification,Cancer Related,Autopsy,Genetic mutation,450,Hemophiliac,1000,Comprehensive Cancer Center (CCC),MD Anderson Cancer Center,Green,Asbestos,No,A5,MethChip_001,A1-01,Not Applicable,H3K27ac,Not Reported,Not Reported,Not Reported,0,1.0,I,Blocking Release,Not Allowed To Collect,Vitamin D3,No,Clonal,No,CRS-2023-01,Not Reported,High Risk,Not Reported,High Risk,No,Hypertension,Chronic Pancreatitis,Histology,2D Classical Conditionally Reprogrammed Cells,0.05,Consent Exemption,No,0.001,0.02,Adrenal,0,copy_number_variation_report.pdf,0,GATK4_CNV,1,Whole Genome Sequencing Analysis,Antigua and Barbuda,Andorra,1,2023-01-15T14:30:00Z,1614556800,Dr. Susan O'Reilly,50,1q21.1,Clinical,ADF,FASTQ,ER-positive,Aggregated Somatic Mutation,Genomic Sequencing Data,5,14,-3285,1,0,0,0,0,7,0,1,-328,-32872,0,0,45,45,45,-365,0,0,3,28,0,phs000424,Age,Gene_expression_quantification.csv,Basal cell carcinoma,Biguanide,Breast cancer,True,No,0,DU-Disease Unchanged,Complex Mixed and Stromal Neoplasms,Adjacent (< or = 2cm),DISTR-00123CA,85,10.1038/nrc.2017.104,No,No,Glucocorticoid,High Grade,Epithelial,0,College Degree,Adverse,Gelfoam,Sanger,High Grade (G2),No Metastasis (M0),Not Reported,Extracompartmental (T2),M0,N0,Stage I,T1,No,5.2,file_format,High Grade Dysplasia,No,Unknown,Convincing Image Source,Biopsy with Histologic Confirmation,1 to 2 Days,exon1,sample_protocol.pdf,CellProliferation_Assay_HD33,Allprep RNA Extraction,Gene Expression Profiling,ATAC-Seq,Not Reported,0.5,1,Home,Asbestos,Tobacco smoke,RNA-Seq data analysis,Extensive,No,Gross Extension,True,Minimal (T3),Amber,M0,Breast cancer,sample1_R1_001.fastq,75.2,72.5,75,72,Stage IA,1988,BRCA1_sequence.fasta,512,deleted,BRCA1_sequence.fasta,1,Censored,0-30 Days,Altered Mental Status,FCB12345X6,Initial diagnosis,150,200,100,35.2,MboI,Liquid nitrogen immersion,No,female,BRCA1_upregulated,ARNT,Whole Genome Sequencing Alignment,GATK Best Practices for Germline SNP & Indel Discovery,Group 1,Pattern 4,5,6,No,0.5,45.2,24,No,150,No,Anaplastic,H1,CENP-A,No,Colorectal Cancer,0.05,Not Reported,Current User,Estrogen only,26,HPV16,Bladder,Hysterectomy,C50.9,C50.9,root,Good Prognosis,Breast,2023-01-15,Carcinomatosis,Indeterminate,2.5,2.5,99mTc Bone Scintigraphy,Anti-TNF Therapy,True,True,Diagnosis,Initial Diagnosis,45.2,Differentiating,Favorable,L1,Not Reported,454 GS FLX Titanium,2023-07-15,2.5,High Risk,intron-1,Group II,1,True,True,0 - No Fibrosis,I,10,FAIL,Blast Count,1,Macroscopic (2cm or less),Biochemical evidence of disease without structural correlate,Bilateral,2015-03-12T08:47:30Z,2021-03-15T14:30:00Z,1,OncogeneExpress,NEBNext Ultra II DNA Library Prep Kit for Illumina (E7645),TruSeq Stranded mRNA,Illumina,TruSeq RNA v2,Affinity Enrichment,First_Stranded,ATAC-Seq,0,1,BRCA1 17q21,2.5,No,Functional (Limited) Neck Dissection,Neck,Cervical,Indeterminant,0,No,0,No,40,1,0.1,Indeterminant,Gerota Fascia,Divorced,Stage I,CGI_1001_Hypermethylated,KRAS_G12D,Maxilla,e4da3b7fbbce2345d7772b0674a318d5,30X,Echographic,Centimeters,Non-WNT/non-SHH Activated,No,Not Reported,No,Distant Metastasis,Ascites,Autopsy,Blood Draw,Bisulfite Conversion Quality Control,0.85,Bisulfite-Seq Liftover,No,Absent,1,microRNA-seq,hsa-miR-21-5p,No,High,1,1500,Cytogenetics,5 Prime UTR Variant,BRCA1/2 mutation analysis,Cohesive,8005/0,0.5,MSI,BCR123A4X,12,Class I,15,LOH,mdanderson.org,0.5,No,True,True,True,True,Absent,No,Acetaminophen,No,Patient shows signs of metastasis,100,1,1,50,1,Medical Doctor,Yes-OCT-Embedded,Tumor Grade,Not Reported,Absent,FAIL,No,Continuous,0.0,120,1998,Type 1,Primary tumor biopsy,No,1,Benign,Invasive ductal carcinoma,4f123bca-9e6f-4c8e-ba17-e31a6432f347,Invasive ductal carcinoma,Nephrectomy specimen with tumor confined to the kidney; distant metastasis identified at diagnosis,FAIL,FAIL,FAIL,FAIL,FAIL,FAIL,2.5,5.2,40,2.5,12.5,2.5,2.5,0.5,2.5,98.5,0,0,5.2,0.5,5.2,5.2,No,0,0,Atypical,Negative,BRCA1_Mutation_Screen,A01,Affymetrix SNP 6.0,Illumina HiSeq,Aneuploid,25468954,P01,0-1 servings/day,0,Ectopic Pregnancy,No,No,50 mg,Cryopreserved,Atypical meningioma,True,Pattern 1,Anus and anal canal,Not Allowed To Collect,No,dna-seq skip,Colonoscopy,Early Detection and Screening,No,Acoustic nerve,Biochemical,Oncogene Target Discovery,CRS-2023-01,1. Genomic Profiling of Breast Cancer,0.002,0.95,0.95,0.08,0.95,0.02,0,12,0,HER2,321P2,Unknown,No,No,Illumina Infinium HumanMethylation450,RG001_PatientA_Tumor,Average Base Quality,Illumina_HiSeq_2500,50,Not Applicable,Adverse Event,Adverse Event/Complications,1,2.5,Antacids,First-line chemotherapy,gene_expression_data.csv,Genomic_Sequence_Data,35,female,Bladder Cancer,Foster Brother,No,No,no,0,True,2023-01-15,True,True,True,Not Reported,R0,1-10 mm,No,1,0,No,2.1,10.0,Alcoholic Liver Disease,Biochemical Assessment,No,Smoking,Bulk RNA-Seq,10.0,Primary,Oral,sample_alignment.bam,1,Benign Neoplasms,1,Tumor biopsy,0,No,Absent,Acetate,v1.0.0,E2,ERBB3,Gene expression profiling,Pattern 1,No,Breast,True,True,True,True,FAIL,FAIL,Broad Institute,2021-03-15,MDACC,2.5,BRCA1 mutation,TP53 mutations,Chromium 3' Gene Expression v2 Library,Cardia,Lymph nodes,1,2.5,<10 nm,H&E_stained_lung_carcinoma,H&E stained,Every day,MuTect2,Mutect2,GISTIC2.0,MuTect2,KRAS_G12D,Telomerase Activity Assay,3D Organoid,UV-Vis Spectroscopy,0.5 nM,ERCC_SpikeIn.fasta,5.2,Haemotoxylin and Eosin (H&E),3 Point Scale,0,invalid,Sample contaminated,Approved,Manta,Deletions,True,TumorSample1_R1.fastq.gz,BRCA1_mutation_profile,Affymetrix SNP Array 6.0,0.856,0.85,SRR1234567.bam,BioGenX23_StudyA,Cerebral Cortex,No,Oncogene Activation,Custom GENIE-DFCI Oncopanel - 447 Genes,SureZyme-TC1001,SureSelect Human All Exon V6,SureSelect Human All Exon V6,Agilent Technologies,SureSelectXT Human All Exon V6,DNA,Abnormal,Not Reported,2.5,0-25,Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999,True,No,>14 mg/L,2,5,31-60 Minutes,Adjuvant Therapy,Prospective,A1-01,Anterior surface of epiglottis,Lung,Abnormal,True,1970,1985,2,100000,1024,ENST00000367770.8,Absent,Axilla,Breast,A081105,100,50,IU/kg,28,Complete Necrosis (No Viable Tumor),No,Every 24 Hours,Adjuvant,no,Complete Response,45,Antiseizure Treatment,Chemotherapy,0.5,Acute Leukemia of Ambiguous Lineage (ALAL),1,No,1.2,Deep,1.2,NOS,Multifocal,G2,Four Tier,Few,Few,1.2,2.5,Peripheral zone,1,0.95,0,Diffuse,0.5,2.5,data_release,Accidental building fire smoke,Cigar,M0,N0 (i+),Stage IA,T0,M0,N0,Stage IA,Not Reported,1st,No,No,6,Bilateral,Hormones,No,Bilateral,2023-01-15T14:30:00Z,0,Germline,Alleles,No,Extramural,HBV Core Antibody,Alive,24,45.5,Nuclear grade,0,A01,0x-10x,Grade I,G1,Favorable,2023-07-15T14:30:00Z,`https://github.com/cancer-genomics/workflow1/commit/a1b2c3d4e5,2023-01-15T08:30:00,ABSOLUTE LiftOver,1.0.0,1902,2015,2005,1,0,Central zone,Hemizygous
1.9,G12D,Not Reported,Nextera_Transposase_Sequence,CTGTCTCTTATACACATCTCCGAGCCCACGAGAC,Bilateral ovaries with endometriotic cyst and surface adhesions,Not Reported,Dry Skin,Grade 2,14610,5,24,12,False,KRAS mutations,Cryptococcosis,M1,N0 (mol-),Stage IA2,T2a,M1a,N1a,Stage 0a,T1b2,2nd,1.0,0.5,Weekly Drinker,Not Reported,Heavy Drinker,Liquor,normal_sample_01.bam,R2_78901,2. Cross-Species Contaminant Removal,Bowtie2,100,100,Tumor biopsy FFPE,1.2,mutation_load_analysis.xlsx,4.0,EBV Immortalized Normal,E,100,BRCA2,Not Reported,Diffuse,Trisomy,Not Allowed To Collect,Night Sweats,Stage I,Not Allowed To Collect,Stage I,TP53_R175H,CD15,Genomic Data Commons (GDC),Not Reported,Crocidolite,28.7,200,100,False,Not Reported,GATK HaplotypeCaller,Albacore_2.3.4,Not Reported,202,BCR-CD02,IPD-Immunoprogression,Bile Duct,Left,Collagenase,Buccal Mucosa,2.0,135.0,150.0,22.3,1.63,Not Reported,0.8,Immunodeficiency-associated,Screening,Lung cancer,HCMI-00456,Biospecimen identity unknown,Cardiovascular Disorder,Death Certificate,Immunotherapy response,560,Heterosexual Contact,5000,Basic Research Center (BRC),Memorial Sloan Kettering Cancer Center,Red,Benzene,Not Reported,B,MethChip_002,B2-05,Unknown,H3K27me3,Unknown,Unknown,p,1,1.5,II,CenterNotification,Premalignant,Omega-3 Fatty Acids,Not Reported,Non-clonal,Unknown,ONC-2023-02,Stage I,Intermediate Risk,Stage I,Intermediate Risk,Not Reported,Diabetes mellitus,Cirrhosis,Not Reported,2D Modified Conditionally Reprogrammed Cells,0.1,Consent Waiver,Not Reported,0.005,0.05,Bladder,1,segmented_data_summary.xlsx,1,Broad_CGH_Liftover,3,Targeted Sequencing Analysis,China,Aruba,2,2023-02-20T09:15:00Z,1614643200,Prof. James P. Allison,120,3p14.2,Combined Nucleotide Variation,BCR Biotab,BAM,HER2-positive,Aligned Reads Index,Transcriptomic Data,12,28,-6570,3,15,1,45,7,14,30,3,45,-14500,45,1,60,60,90,-730,1,1,7,45,1,phs000425,Gender,Copy_number_variation_data.csv,Squamous cell carcinoma,Diet,Lung cancer,False,Not Allowed To Collect,1,Non-CR/Non-PD-Non-CR/Non-PD,Cystic,Distal (>2cm),DISTR-00234BC,92,10.1158/1078-0432.CCR-18-2367,Not Reported,Not Reported,Growth factor,Indefinite,Esophageal Columnar Dysplasia,1,High School Graduate or GED,Favorable,Lipiodol,Illumina 1.5,Low Grade (G1),Not Reported,Stage IA,Intracompartmental (T1),M1,N1,Stage II,T2,Unknown,12.7,file_size,Indefinite for Dysplasia,Not Reported,hispanic or latino,Histologic Confirmation,Convincing Image Source,3 to 4 Days,exon2,data_collection_methodology.docx,ApoptosisRate_MCF7_Cisplatin,Chemical Lysis DNA Extraction,Whole Genome Sequencing,ChIP-Seq,Six Weeks or More,1.0,2,Occupational,Chemical,Ultraviolet radiation,Differential gene expression analysis,Focal,Unknown,Microscopic Extension,False,Moderate/Advanced (T4a),Blue,M1,Colorectal cancer,sample1_R2_001.fastq,68.9,68.9,89,85,Stage IB1,1995,Tumor_sample_01.bam,1024,error,TumorImaging_MRI.dcm,2,Death,31-90 Days,Headaches,FCB23456Y7,3-month follow-up,200,250,150,47.8,Not Applicable,Cryopreservation with DMSO,Not Reported,male,TP53_downregulated,BMP5,Variant Calling Workflow,Mutect2 in tumor-only mode,Group 2,Pattern 5,10,7,Not Reported,1.2,88.9,30,Not Reported,162,Not Reported,Not Reported,H2A,H2A-Bbd,Not Reported,Lower Grade Glioma,0.1,Progestin,Former User,Not Reported,33,HPV18,Macroscopic Parametrium,NOS,C34.1,C34.1,root,Intermediate Prognosis,Lung,2023-02-20,Kidney Involvement,Negative,4.1,4.1,CT Scan,Azathioprine,False,False,First Patient Visit,Not Reported,30.5,Not Reported,Not Reported,L2,Stage 1,Illumina Genome Analyzer IIx,2023-09-01,4.8,High-Intermediate Risk,intron-2,Group IIIa,2,False,False,"1,2 - Portal Fibrosis",II,100,Not Reported,Circulating Endothelial Cells,2,Macroscopic (greater than 2cm),Distant met recurrence/progression,Left,2016-07-26T14:22:15Z,2022-06-20T09:15:00Z,2,TumorSuppressorSeq,KAPA HyperPrep Kit (KK8504),NEBNext Ultra II DNA,Thermo Fisher Scientific,Nextera XT v2.5,Hybrid Selection,Not Applicable,ChIP-Seq,1,2,TP53 17p13.1,4.8,Unknown,Modified Radical Neck Dissection,Left,Lateral,Negative,1,Not Reported,1,Not Reported,100,2,0.5,Involved,Parenchyma,Domestic Partnership,Stage III,CGI_2045_Hypomethylated,TP53_R175H,Mediastinal lymph nodes,1679091c5a880faf6fb5e6087eb1b2dc,60X,Pathologic,Millimeters,Not Determined,Not Reported,Perimenopausal,Not Reported,Metastasis,Kidney,Cystoscopy,Bone Marrow Aspirate,Cross-Platform Normalization,0.67,WGBS to hg38,Not Reported,Not Reported,2,qRT-PCR,hsa-miR-155-5p,Not Reported,Intermediate,2,2300,NOS,Coding Sequence Variant,EGFR mutation test,Cribiform,8013/3,1.2,MSS,MUX0987Z1,13,Class II,32,MSI,mskcc.org,2.3,Not Reported,False,False,False,False,Indeterminate,Not Reported,Aspirin,Not Allowed To Collect,Biomarker levels indicate aggressive progression,200,2,5,120,3,Nurse,No-OCT-Embedded,Lymphovascular Invasion,Ovarian Capsule Fragmented,Indeterminate,Not Reported,Not Reported,Intermittent,0.5,450,2001,Type 2,Blood sample,Not Reported,2,Likely Benign,Lobular carcinoma in situ,5e2fbc3e-8a59-4ec9-8b24-2a8b8f4fd7e6,Ductal carcinoma in situ,Nephrectomy specimen with tumor confined to the kidney; no distant metastasis,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,7.8,12.7,42,7.8,23.8,7.8,7.8,2.3,5.0,95.2,5,5,12.8,2.3,12.7,12.8,Not Reported,1-3,1,Malignant,Not Reported,LungCarcinoma_Panel1,B02,Complete Genomics,Affymetrix GeneChip,Diploid,26786412,P02,2-3 servings/day,1,Induced Abortion,Not Reported,Not Reported,100 mg,EDTA,Carcinoma,False,Pattern 2,Brain,no,Not Allowed To Collect,dna-seq skip,Endoscopy,Immunotherapy Research,Not Allowed To Collect,Connective,Distant,Precision Immunotherapy Trials,ONCO-GEN-09,2. Immunotherapy in Melanoma Treatment,0.005,0.87,0.98,0.12,0.89,0.05,1,18,5,EGFR,3881,american indian or alaska native,Not Reported,Not Reported,Illumina Infinium HumanMethylation27,RG002_PatientA_Normal,Total Reads,Ion_Torrent_PGM,75,R1,Course of Therapy Completed,Not Done per Treating Physician's Discretion,2,4.8,H2 Blockers,Second-line chemotherapy,patient_demographics.xlsx,Histopathological_Images,42,male,CNS Cancer,Full Brother,Not Reported,Not Reported,not reported,1,False,2023-02-20,False,False,False,R0,R1,11-20 mm,Unknown,2,5,Not Reported,1.8,9.5,Allergy,Both Clinical and Biochemical Assessments,Not Reported,Alcohol consumption,Single-cell RNA-Seq (scRNA-Seq),9.5,Secondary,Intravenous,quality_metrics.json,2,Blood Derived Cancer - Bone Marrow,3,Blood sample,5,Not Reported,Indeterminate,Axumin,v1.2.3,E5,FES,Protein expression analysis,Pattern 2,Not Reported,Lung,False,False,False,False,Not Reported,Not Reported,Genentech,2021-07-22,DFCI,1.2,BRCA2 mutation,KRAS mutations,Chromium 3' Gene Expression v3 Library,NOS,Liver,2,4.1,10-30 nm,Immunofluorescence_labeled_breast_cancer,Immunofluorescence,Some days,VarScan2,Strelka2,ABSOLUTE,VarScan2,TP53_R175H,Circulating Tumor Cell Analysis,Derived Cell Lines and Sorted Cells,NanoDrop,1 nM,SIRV_Set3.fasta,12.8,Immunohistochemistry (IHC),4 Point Scale,1+,legacy,Insufficient sample volume,Rescinded,Delly,Duplications,False,TumorSample1_R2.fastq.gz,TP53_variant_analysis,Illumina HumanOmniExpress-24,0.342,1.02,SRR7654321.bam,OncoLab45_TrialB,Deep Gray (e.g. Basal Ganglia,Not Reported,Tumor Suppressor Genes,Custom MSK IMPACT Panel - 468 Genes,GeneLock-TCK2580,TruSeq Exome Enrichment Kit,TruSeq Exome Enrichment,Roche NimbleGen,TruSeq Exome Enrichment Kit v3,Not Reported,NOS,U/g Hb,7.8,1-49%,Anti-CD30 Monoclonal Antibody XmAb2513,False,Not Reported,>14 mg/L,5,10,6-30 Minutes,End of Consolidation Therapy,Retrospective,B2-05,Anus,Breast,Normal,False,1982,1990,3,250000,2056,NM_007294.4,Not Reported,Cerebellum,Lung,A081801,200,100,g/day,45,Incomplete Necrosis (Viable Tumor Present),Not Reported,Every Hour,Androgen Deprivation Therapy (ADT),not reported,Mixed Response,90,Biopsy,Radiation therapy,1.2,Acute myeloid leukemia (AML),4,Not Reported,3.5,Not Reported,3.5,New Primary,Not Reported,G3,Not Reported,Many,Many,0.8,4.8,Transitional zone,2,0.85,1,Dome,0.8,4.8,data_release,Cooking-related smoke,Cigarette,M1,N1,Stage IA1,T1a,M1,N0 (mol+),Stage IA1,T0,2nd,Not Reported,Not Reported,12,Left,Not Reported,Not Reported,Left,2023-02-03T09:15:00Z,1,Somatic,Conversion,Not Reported,Intramural,HBV DNA,Dead,26,68.2,Mitotic rate > 5/50 HPF,1,B02,10x-25x,Grade II,G2,Not Reported,2023-08-22T09:45:00Z,https://github.com/genome-research/workflow2/commit/f6g7h8i9j0,2023-02-20T09:45:00,AscatNGS,1.2.1,1906,2016,2006,2,1,Overlapping/multiple zones,Heterozygous
1.95,T790M,PASS,TruSeq_Universal_Adapter,GATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT,Bone marrow concordant histology,Yes,Duodenal Ulcer,Grade 3,8035,12,30,18,False,APC mutations,Cryptosporidiosis,M1a,N1,Stage IB2,T2b,M1b,N1b,Stage IA1,T1mi,3rd,2.0,1.0,Weekly Drinker,Unknown,Lifelong Non-Drinker,Not Reported,patientA_tumor_rep1.bam,R3_34567,3. PCR Amplification Artifact Reduction,STAR,150,150,Blood plasma,2.5,patient_demographics.json,1.2,FFPE DNA,G,150,PSA,Unknown,Equivocal,Trisomy,Not Reported,Other,Stage II,Not Reported,Stage II,BRAF_V600E,CD20,Oncomine,Unknown,Amosite,30.4,250,125,False,Unknown,DeepVariant,Bonito_0.3.6,PASS,303,BCR-EF03,MR-Minimal/Marginal Response,Bladder,Not Reported,Trypsin-EDTA,Embryonic Fluid,0.5,3.5,6.1,24.9,1.74,Unknown,1.0,adult,Surveillance,Prostate cancer,HCMI-00789,Center QC failed,NOS,Medical Record,Chemotherapy resistance,320,Homosexual Contact,10000,Clinical Research Center (CRC),Johns Hopkins Sidney Kimmel Comprehensive Cancer Center,Red,Formaldehyde,Unknown,B7,MethChip_003,C3-10,abcam ab4729 anti-H3K27ac,H3K36me3,t(10;11)(p11.2;q23),chr11,q,5,2.0,III,Complete Data Freeze,Prior primary,Probiotics,Yes,Clonal,Yes,GEN-2023-03,Stage II,Low Risk,Stage II,Low Risk,Unknown,Chronic kidney disease,Unknown Etiology,Pathology,3D Neurosphere,0.25,Consent by Death,Yes,0.01,0.1,Colon,2,CNV_analysis_presentation.ppt,2,Pindel_Liftover,5,Comparative Genomic Hybridization,Denmark,Belize,3,2023-03-05T16:45:00Z,1614729600,Dr. Elizabeth Blackburn,200,5q35.3,Copy Number Variation,BEDPE,VCF,Triple-negative,Allele-specific Copy Number Segment,Proteomic Data,18,42,-4380,7,30,2,90,14,21,60,7,180,-7300,90,3,90,90,120,-1095,3,3,14,60,3,phs000426,Ethnicity,Methylation_data.csv,Malignant melanoma,Insulin,Prostate cancer,True,Not Reported,2,Not Reported,Mucinous and Serous Neoplasms,Not Reported,DISTR-00345LC,78,10.1016/j.cell.2018.02.065,Yes,Yes,PARP inhibitor,Low Grade,Esophageal Mucosa Columnar Dysplasia,2,Not Reported,Intermediate,Other,Illumina 1.8,Not Reported,Regional or Distant Metastasis (M1),Stage IB,Not Reported,M1,N1,Stage III,T3,Yes,18.9,md5sum,Low Grade Dysplasia,Unknown,not allowed to collect,Convincing Image Source,Histologic Confirmation,5 or More Days,exon3,control_group_details.xlsx,GeneExpression_T47D_Estrogen,HighPure miRNA (Allprep DNA) FFPE RNA,Targeted Therapy Evaluation,Genotyping Array,Unknown,1.5,5,Secondary,Coal Dust,Asbestos,Single-cell RNA sequencing (scRNA-seq) analysis,Not Reported,Yes,No Extranodal Extension,True,,Brown,M2,Lung cancer,tumor_sampleA_R1.fastq,82.5,74.3,92,93,Stage IC,2009,Patient3_VHL_mutation.vcf,2048,processed,PatientMetadata.xlsx,3,Death without Remission,91-180 Days,Motor or Movement Changes,FCB34567Z8,6-month follow-up,250,300,200,52.1,Unknown,Slow programmable freezing,Unknown,not reported,EGFR_overexpressed,CARS,RNA-Seq Quantification,HaplotypeCaller,Group 3,Pattern 4,15,8,Unknown,2.4,150.5,36,Unknown,175,Unknown,Poorly differentiated,H2B,H2A.Z,Yes,Phenochromocytoma or Paraganglioma,0.2,Progestin and Estrogen,Never Used,Progesterone and Estrogen,35,HPV33,Microscopic Parametrium,Not Performed,C18.9,C61,root,Not Reported,Brain,2023-03-10,Liver Involvement,Not Performed,3.7,6.7,MRI,Cyclophosphamide,True,False,First Treatment,Persistent Disease,55.8,Poorly Differentiated,Unfavorable,M,Stage 2A,Illumina HiSeq 2000,2023-11-20,7.1,Low Risk,intron-3,Group IIIb,3,True,True,"3,4 - Fibrous Septa",III,20,PASS,Creatinine,3,Microscopic,Loco-regional recurrence/progression,Midline,2017-05-30T09:55:00Z,2023-01-05T11:45:00Z,3,MetastaMap,TruSeq DNA PCR-Free Library Preparation Kit (20015964),KAPA Stranded RNA-Seq,Qiagen,QIAseq UPX 3' Transcriptome v1,Other,Second_Stranded,HiChIP,2,5,EGFR 7p11.2,7.3,Yes,Radical Neck Dissection,Neck,Epitrochlear,Not Reported,2,Yes,2,Unknown,200,3,1.0,Not Reported,Perinephric Fat,Married,Stage IIa,CGI_3250_Unchanged,BRAF_V600E,Ovary,8f14e45fceea167a5a36dedd4bea2543,100X,Radiologic,Centimeters,Not Reported,Yes,Postmenopausal,Unknown,NOS,Liver,Enucleation,Endolaryngeal Excision,Beta Value Calibration,0.72,Cross-Species Methylation Mapping,Unknown,Present,3,NanoString nCounter,hsa-miR-16-5p,Unknown,Low,3,1800,Flow Cytometry,Mature miRNA Variant,ALK gene rearrangements,Micropapillary,8162/3,2.8,MSI,IDX456C2V,61,Class III,50,Normal_LogR,dana-farber.org,4.7,Yes,False,False,True,False,Not Reported,Unknown,Metformin,Not Reported,Family history of similar cancer types noted,300,3,10,200,5,Laboratory Technician,OCT-Embedding-Confirmed,Perineural Invasion,Ovarian Capsule Intact,Not Reported,PASS,Unknown,Intermittent,1.5,75,2003,Type 1,Adjacent normal tissue,Yes,3,Likely Pathogenic,Ductal carcinoma in situ,7a8b9c1d-4567-48d2-8e20-55a8c2d38e79,Lobular carcinoma in situ,Nephrectomy specimen with tumor that is present at the surgical margin of resection or within regional lymph nodes; distant metastasis identified at diagnosis,PASS,PASS,PASS,PASS,PASS,PASS,12.3,23.5,45,12.3,7.2,12.3,12.3,10.0,7.8,87.0,10,10,23.4,5.0,23.5,23.5,Unknown,4 or More,2,Non-Malignant,Positive,Melanoma_BRAF_Assay,C03,Illumina Human Methylation 27,Ion Torrent PGM,Hyperdiploid,27830973,P03,4-5 servings/day,2,Live Birth,Unknown,Unknown,150 mg,FFPE,metastatic,True,Pattern 3,Breast,not reported,Not Reported,dna-seq skip,Not Reported,Genetic Counseling and Testing,Not Reported,subcutaneous and other soft tissues of abdomen,Local,Metastasis Prevention Strategy,MEL-TRIAL-2023,3. Lung Cancer Screening and Early Detection,0.007,0.92,0.99,0.15,0.92,0.1,2,25,10,PD-L1,8605,asian,Unknown,Unknown,Illumina Infinium MethylationEPIC,RG003_PatientB_Tumor,Mapped Reads,Oxford_Nanopore_MinION,100,R2,Death,Not Reported,3,7.1,Medically Treated,Adjuvant chemotherapy,treatment_outcomes.pdf,Clinical_Trial_Results,50,not reported,Gallbladder Cancer,Maternal Great Aunt,Yes,Yes,unknown,2,True,2023-03-05,True,False,True,R1,R2,>20 mm,Yes,3,10,Yes,2.0,8.7,Nuts,Clinical Assessment,Unknown,Obesity,Spatial Transcriptomics,8.7,Tertiary,Intramuscular,variant_calls.vcf,3,Post-treatment,5,Saliva,10,Yes,Not Reported,Choline,v2.0.0,E8,H3F3B,miRNA expression profiling,Pattern 3,Unknown,Colon,False,True,True,False,PASS,PASS,Illumina Clinical Services Laboratory,2021-11-30,MSKCC,3.8,TP53 mutation,EGFR mutations,Chromium scATAC v1 Library,Hypopharyngeal aspect of aryepiglottic fold,Lung,3,3.7,31-50 nm,Papanicolaou_stain_cervical_cancer,Frozen section,Unknown,Strelka2,VarScan2,FACETS,Strelka2,BRAF_V600E,Microsatellite Instability Testing,Granulocytes,Qubit Fluorometric Quantitation,2.5 nM,PhiX174.fasta,23.4,Immunohistochemistry (IHC),3 Point Scale,2+,md5summing,Patient consent withdrawn,Approved,GRIDSS,Translocations,False,NormalSample1_R1.fastq.gz,EGFR_exon_19_deletions,Agilent SurePrint G3,0.675,0.92,SRR2345678.bam,CellPath9_ProjectC,Thalamus),Unknown,Immunotherapy,Custom PGDX SureSelect CancerSelect VAREPOP-APOLLO Panel - 203 Genes,OncoTarget-5002,NimbleGen SeqCap EZ Exome v3,NimbleGen SeqCap EZ Exome v3,Illumina,NimbleGen SeqCap EZ Exome v3.0,Protein,Amplified,U/mL,0.1,10-19%,Anti-CD70 CAR-expressing T Lymphocytes,True,Unknown,>14 mg/L,7,15,After 60 Minutes,End of Treatment Course 2,Retrospective,C3-10,NOS,Colon,Not Allowed To Collect,False,1995,1995,4,500000,5120,NM_000546.6,Present,Cerebrospinal Fluid,Prostate,E4512,300,150,mL,60,No Known Treatment Effect,Unknown,Every Other Day,Consolidation Therapy,unknown,No Measurable Disease,120,Incisional,Immunotherapy,2.4,CNS,20,Unknown,0.8,Superficial,0.8,Not Allowed To Collect,Unifocal,G4,Three Tier,Moderate,Moderate,3.5,7.1,Central zone,3,0.75,2,Mushroom,1.2,1.2,data_release,NOS,Electronic Cigarette,M1a,N1b,Stage IA3,T1c,M1b,N1bI,Stage IB,T1,3rd,Yes,Yes,18,Not Reported,Orchiopexy,Yes,Not Reported,2023-03-22T17:45:00Z,2,Unknown,Deletion,Unknown,Macro,HBV Genotype,Not Reported,28,70.1,Atypical mitoses,2,C03,150x+,Grade III,G3,Unfavorable,2023-09-05T16:15:00Z,https://github.com/precision-oncology/workflow3/commit/k1l2m3n4o5,2023-03-10T14:00:00,BCGSC miRNA Profiling,2.0.0,1910,2017,2007,3,2,Peripheral zone,Homozygous
2.0,L858R,Unknown,SOLiD_Adapter,TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG,Clostridioides difficile (c. diff),No,Generalized Muscle Weakness,Grade 4,21915,18,35,24,False,EGFR mutations,Chronic Intestinal,M1b,N1a,Stage IIA,T4,M1d,N1bII,Stage IA3,T2,4th,3.0,1.5,Weekly Drinker,Yes,Non-Drinker,Other,patientA_normal_rep1.bam,R4_89012,4. Read Quality Filtering,HISAT2,200,200,Blood serum,5.0,treatment_response_data.xml,0.8,FFPE RNA,H,200,CA-125,Yes,Focal,Monosomy,Unknown,Weight Loss,Stage III,Unknown,Stage III,PIK3CA_E545K,CD33,Cancer Cell Line Encyclopedia (CCLE),Yes,Amosite,22.5,300,150,True,Yes,Nanopore Guppy,Guppy_5.0.7,Unknown,404,BCR-GH04,Non-CR/Non-PD-Non-CR/Non-PD,Cecum,Right,Penicillin-Streptomycin,Granulocyte,3.0,12.0,7.45,27.5,1.85,Yes,1.2,Immunodeficiency-associated,Symptomatic,Colorectal cancer,HCMI-01011,Clinical data insufficient,End-stage Renal Disease,Not Reported,Radiation therapy effect,750,Intravenous Drug User,15000,Cancer Prevention Center (CPC),Dana-Farber Cancer Institute,Green,Vinyl chloride,Yes,B8,MethChip_004,D4-15,Not Applicable,H3K4me1,t(11;19)(q23;p13.1),chr20,p,10,2.5,IV,Downstream Data Freeze,Synchronous primary,Turmeric (Curcumin),No,Clonal,No,IMM-2023-04,Stage III,Not Reported,Stage III,Not Reported,Yes,Coronary artery disease,Denys-Drash Syndrome,Radiology,Buccal Cells,0.5,Informed Consent,No,0.015,0.03,Inferior Vena Cava,3,QC_metrics_for_CNVs.csv,3,CNVnator_v0.3,7,SNP Array Analysis,Federated States of Micronesia,France,4,2023-04-10T11:00:00Z,1614816000,Dr. Carl June,75,7p22.1,DNA Methylation,CEL,DICOM,KRAS mutation,Clinical Supplement,Metabolomic Data,24,56,-7300,14,45,3,120,30,30,90,14,365,-3650,120,5,120,120,180,-1460,5,7,21,90,7,phs000427,Socioeconomic Status,Protein_expression_data.csv,Breast carcinoma,Linagliptin,Colorectal cancer,True,Unknown,3,PR-Partial Response,Fibromatous Neoplasms,Unknown,DISTR-00456MC,65,10.1126/scitranslmed.aaf6853,No,Yes,Glucocorticoid,Mild,Keratinizing,3,Professional or Graduate Degree,Not Reported,PVA Particles,Solexa,Unknown,Unknown,Stage IIA,Unknown,M1,N1,Stage IV,T4,No,23.5,file_size,Negative/ No Dysplasia,Yes,not hispanic or latino,Convincing Image Source,Physical Examination,,exon4,experimental_group_setup.txt,MigrationAssay_PC3_Control,Pre-extracted DNA received by TSS,Proteomics,Methylation Array,Six Weeks or More,2.0,10,Social,Dust,Radon gas,Gene set enrichment analysis (GSEA),Focal,Yes,Gross Extension,False,Unknown,Gray,M3,Prostate cancer,tumor_sampleA_R2.fastq,70.1,80.1,103,67,Stage IC2,1988,LungCarcinoma_RNAseq.fastq,4096,processing,GeneExpression_RNAseq.csv,4,Induction Failure,>=181 Days,Not Reported,FCB45678A9,9-month follow-up,300,350,250,60.5,MboI,Vitrification,Yes,unknown,HER2_amplified,CLTCL1,Copy Number Variation Analysis,DeepVariant,Group 4,Pattern 4,20,9,Yes,3.1,75.3,48,Yes,158,Yes,Unknown,H3,H2A.Z.2,No,Phenochromocytoma or Paraganglioma,0.35,Unknown,Not Reported,Progesterone only,39,HPV39,,Not Reported,C67.9,C18.7,root,Poor Prognosis,Liver,2023-04-05,Lung Involvement,Not Reported,5.2,3.2,PET,Methotrexate,False,False,Initial Genomic Sequencing,Progressive Disease,60.1,Undifferentiated,Unknown,Ms,Stage 2B,Illumina HiSeq X Five,2024-01-05,9.3,Low-Intermediate Risk,intron-4,Group IIa,4,True,False,5 - Nodular Formation and Incomplete Cirrhosis,Not Reported,30,Unknown,Human Chorionic Gonadotropin,4,Not Reported,Not Allowed To Collect,Not Reported,2018-01-19T16:33:45Z,2021-07-22T16:00:00Z,4,CarcinomaCellLib,Nextera DNA Flex Library Prep Kit (20018705),SMARTer Stranded Total RNA-Seq Kit,NEB (New England Biolabs),SMARTer Stranded Total RNA-Seq Kit v2,PCR,Unstranded,RNA-Seq,3,10,KRAS 12p12.1,10.1,Unknown,Radical Neck Dissection,NOS,Hilar,Positive,3,No,3,Yes,400,4,1.5,Uninvolved,Renal,Never Married,Stage IIb,CGI_4120_Hypermethylated,PIK3CA_E545K,Pancreas,c9f0f895fb98ab9159f51fd0297e236d,150X,Pathologic,Centimeters,SHH-Activated,Yes,Premenopausal,Yes,No Metastasis,Lung,Excisional Biopsy,Needle Biopsy,Probe Annotation Alignment,0.45,Methylation Array to NGS Liftover,Yes,Unknown,4,microarray analysis,hsa-miR-34a-5p,Yes,Not Reported,4,1250,Immunofluorescence,Missense Variant,PD-L1 expression,Non-cohesive,8251/3,3.4,MSI,BAR789X1Y,12,Class IV,72,Paired_LogR,sanger.ac.uk,7.1,No,False,False,False,True,Present,Yes,Statin,Unknown,Previous treatments show partial response,400,4,15,350,8,Pharmacist,OCT-Embedding-Denied,Hormone Receptor Status,Ovarian Capsule Ruptured,Present,Unknown,Yes,Continuous,2.0,300,2005,Type 1,Bone marrow aspirate,No,4,Pathogenic,Invasive lobular carcinoma,9d0e1f2b-3b14-43ad-bb57-c7f29b6d2a1b,Invasive lobular carcinoma,Nephrectomy specimen with tumor that is present at the surgical margin of resection or within regional lymph nodes; no distant metastasis,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,0.9,34.9,47,15.0,34.9,15.0,4.6,15.75,10.3,76.3,15,15,7.9,7.8,34.9,34.1,Yes,Not Reported,3,Not Reported,Not Reported,ColonCancer_KRAS_Test,D04,Illumina Human Methylation 450,Oxford Nanopore MinION,Hypodiploid,28954789,P04,6-7 servings/day,3,Miscarriage,Yes,Yes,200 mg,Fresh,NOS,False,Pattern 4,Eye and adnexa,unknown,Unknown,dna-seq skip,Unknown,Palliative Care Programs,Unknown,Dome of bladder,Locoregional,Breast Cancer Genomics,LUNG-CR-2022,4. Molecular Mechanisms of Pancreatic Cancer,0.01,0.76,0.92,0.2,0.87,0.15,3,30,15,BRCA1,9340,black or african american,Yes,Yes,Affymetrix GeneChip Human Tiling 2.0R Array,RG004_PatientB_Normal,Unmapped Reads,PacBio_RS_II,150,R3,Disease Progression,Participant Refusal,4,9.3,No Treatment,Neoadjuvant chemotherapy,mutation_analysis.json,Patient_Consent_Forms,27,unknown,Kaposi Sarcoma,Maternal Half Sister,No,Yes,yes,3,False,2023-04-10,True,False,False,R2,RX,No macroscopic disease,No,4,15,No,1.5,7.3,Androgen Excess,Not Reported,Yes,Family history of cancer,Targeted RNA Sequencing,7.3,Quaternary,Subcutaneous,expression_quantification.tsv,4,Blood Derived Liquid Biopsy,6,Bone marrow aspirate,15,No,Present,PSMA,v2.1.0,E11,KCNJ5,Methylation status analysis,Pattern 4,Yes,Prostate,False,True,True,True,Unknown,Unknown,National Cancer Institute,2022-01-20,JHH,0.9,MLH1 mutation,BRAF V600E,Smart-Seq2,Lower gum,Bone,4,1.8,51-100 nm,Masson's_trichrome_stain_liver_cancer,Paraffin-embedded,Unknown,GATK4 Mutect2,SomaticSniper,TITAN,GATK4 Mutect2,EGFR_L858R,Chromosome Conformation Capture,Liquid Suspension Cell Line,BioSpectrometer,5 nM,pUC19.fasta,7.9,Haemotoxylin and Eosin (H&E),3 Point Scale,3+,processed,Data quality below acceptable threshold,Rescinded,LUMPY,Inversions,False,NormalSample1_R2.fastq.gz,KRAS_G12C_mutation_detection,Illumina Infinium Omni2.5-8,0.123,1.15,SRR8765432.bam,TumorTrack67_ResearchD,Frontal lobe,Yes,Chemotherapy Resistance,Custom SeqCap EZ HGSC VCRome v2.1 ER Augmented v2,BioPrime-KitX9,Agilent SureSelect XT Human All Exon V7,Agilent SureSelect XT Human All Exon V7,Thermo Fisher Scientific,Agilent SureSelectXT2 Human All Exon V7,Total RNA,Elevated,cells/mL,15.3,20-29%,Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells,False,Yes,>14 mg/L,10,20,Unknown,Follow-up,Retrospective,D4-15,Ciliary body,Pancreas,Not Reported,True,1965,2000,5,750000,768,NM_005157.5,Unknown,Heart,Colorectal,EA5142,400,200,mg,90,No Necrosis,Yes,Five Times Daily,First-Line Therapy,yes,No Response,180,Blinded Study,Hormone therapy,3.8,ependymoma,40,Yes,6.7,Not Reported,4.7,Not Applicable,Unknown,GB,Four Tier,Moderate,Many,2.1,3.3,Anterior fibromuscular stroma,4,0.65,3,Unknown,1.5,3.7,data_release,Machine smoke,Other,M1b,N1bIV,Stage IIA,T2b,M1c,N1c,Stage IB1,T1a,4th,Not Reported,Yes,24,Right,Spontaneous Descent,Not Reported,Right,2023-04-08T12:00:00Z,3,Unknown,Deletion-Insertion,Yes,Micro,HBV Surface Antibody,Unknown,30,55.4,Clear cell percentage > 75%,3,D04,25x-150x,Grade IV,GX,Unknown,2023-10-10T11:00:00Z,https://github.com/bioinformatics-tools/workflow4/commit/p6q7r8s9t0,2023-04-05T16:30:00,DNAcopy,2.5.3,1914,2018,2008,4,5,Transition zone,Not Reported
2.05,E545K,WARN,Ion_Torrent_Adapter,GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG,Diffuse and early nodular diabetic glomerulosclerosis,Not Reported,Hearing Impaired,Grade 5,25550,23,40,30,False,BRAF mutations,Cytomegalovirus,M1c,N1b,Stage III,T4a,M2,N1bIII,Stage IIA1,T2a1,5th,4.0,2.0,Weekly Drinker,no,Not Reported,Unknown,sample02_tumor_aligned_reads.bam,R5_45678,5. Duplicate Read Elimination,Novoalign,250,250,Peripheral blood mononuclear cells (PBMC),10.0,survival_analysis_output.h5,3.6,GenomePlex (Rubicon) Amplified DNA,R,250,AFP,Unknown,Not Reported,Monosomy,Yes,Other,Stage IV,Yes,Stage IV,EGFR_L858R,CD45,International Cancer Genome Consortium (ICGC),Unknown,Crocidolite,37.9,350,175,False,No,Ion Torrent Suite,Albacore_2.1.10,WARN,505,BCR-IJ05,PPD-Pseudoprogression,Diaphragm,Unknown,L-Glutamine,Not Reported,4.5,70.0,5.5,29.1,1.95,Not Reported,1.5,pediatric,Surveillance,Melanoma,HCMI-01314,General,Infection,Social Security Death Index,Hormonal therapy outcome,290,,20000,Pediatric Cancer Center (PCC),Mayo Clinic Cancer Center,Green,Polychlorinated biphenyls (PCBs),Not Reported,B9,MethChip_005,E5-20,abcam ab4729 anti-H3K27ac,H3K4me3,t(3;5)(q25;q34),chr22,p,15,3.0,Not Reported,Notification,Unknown,Green Tea Extract,No,Clonal,Unknown,THER-2023-05,Stage IV,Unknown,Stage IV,Unknown,Unknown,Chronic obstructive pulmonary disease,Diabetic Neuropathy,Unknown,Control Analyte,0.75,Informed Consent,No,0.02,0.07,Kidney,4,normalized_read_counts.txt,4,Manta_DiploidSV,9,Multiplex Ligation-dependent Probe Amplification,Guatemala,Germany,5,2023-05-25T08:30:00Z,1614902400,Dr. Mary-Claire King,90,9q34.2,Proteome Profiling,CSV,NIfTI,EGFR mutation,Gene Level Copy Number Scores,Epigenetic Data,31,70,-14600,21,60,5,150,45,45,180,21,730,-1825,180,7,150,150,210,-1825,7,14,28,120,14,phs000428,Geographic Location,Mutation_annotations.maf,Prostate adenocarcinoma,Not Reported,Melanoma,True,Yes,4,PSR-Pseudoresponse,Germ Cell Neoplasms,Not Reported,DISTR-00567PC,103,10.1016/S1470-2045(19)30150-5,Yes,No,Growth factor,Moderate,Nonkeratinizing,4,Some High School or Less,Unknown,Plastic Beads,Illumina 1.3,Not Reported,Not Reported,Stage IIB,Unknown,M0,N1,Stage IV,T2,Unknown,29.0,file_size,Not Reported,Not Reported,not reported,Convincing Image Source,Positive Biomarker(s),5 or More Days,exon5,gene_expression_methods.csv,InvasionAssay_A549_TGFbeta,Repli-G,Metabolomics,Reverse Phase Protein Array,Unknown,2.5,15,Unknown,NOS,Alcohol consumption,Pathway analysis,Extensive,Unknown,No Extranodal Extension,True,Very Advanced (T4b),Green,M4,Ovarian cancer,normal_sampleB_R1.fastq,88.4,66.7,67,58,Stage IIIAii,1995,KRAS_G12D_Expression.xlsx,8192,released,WholeExome_VCF.vcf,5,,31-90 Days,Seizures,FCB56789B0,1-year follow-up,350,400,300,42.3,MboI,Snap freezing,Not Reported,unspecified,KRAS_mutation_high,ISX,Methylation Array Preprocessing,Strelka2,Group 5,Pattern 4,25,10,Unknown,4.5,30.0,60,No,168,Unknown,Unknown,H4,H2A.Z.2.2,No,Lower Grade Glioma,0.5,Unknown,Unknown,Unknown,45,HPV45,Not Reported,Not performed,C61,C67.9,root,Unknown,Colon,2023-05-25,Normal,Positive,6.8,5.5,Ultrasound,,True,True,Recurrence,Recurrent Disease,25.4,Undifferentiated or Poorly Differentiated,Unknown,Not Reported,Stage 3,Illumina HiSeq X Ten,2024-03-10,12.0,High Risk,intron-5,Group IIb,Not Reported,False,True,6 - Established Cirrhosis,Unknown,40,WARN,Human Papillomavirus,5,Unknown,Tumor free,Right,2019-11-08T11:04:20Z,2022-09-12T10:20:00Z,5,AngioGenes,QIAseq Ultralow Input Library Kit (180493),QIAseq Stranded mRNA,Roche,NEBNext Ultra II RNA Library Prep Kit for Illumina v3,Poly-T Enrichment,Second_Stranded,Targeted Sequencing,4,15,APC 5q22.2,12.6,No,Modified Radical Neck Dissection,Neck,Iliac,Unknown,4,No,4,Unknown,600,5,2.0,Unknown,Renal Capsule,Separated,Stage IVa,CGI_5287_Hypomethylated,PTEN_T167A,Parotid gland,45c48cce2e2d7fbdea1afc51c7c6ad26,200X,Echographic,Centimeters,Unknown,No,Unknown,Unknown,Not Reported,Lymph Node,Laparoscopy,Orchiectomy,Batch Effect Correction,0.55,ENCODE Methylation Liftover,No,Unknown,5,in situ hybridization,hsa-miR-15a-5p,Not Reported,Unknown,5,2000,Karyotype,NMD Transcript Variant,KRAS mutation test,Papillary Renal Cell,8405/0,4.1,MSI,SEQ321H7G,13,Class V,88,exon,genome.wustl.edu,9.8,Not Reported,False,True,False,True,Unknown,Unknown,NOS,Yes,Genetic mutation identified in tumor,500,5,20,450,10,Research Scientist,Embedded-In-OCT,HER2/neu Status,Unknown,Unknown,WARN,Unknown,Intermittent,5.0,180,2007,Type 1,Pleural effusion fluid,No,5,Uncertain Significance,Triple-negative breast cancer,b3d112f4-6fb7-4f93-9c5a-3b5b76f2c491,Triple-negative breast cancer,Nephrectomy specimen with tumor that penetrates the renal capsule or involves the renal sinus with negative margins and negative lymph nodes; distant metastasis identified at diagnosis,WARN,WARN,WARN,WARN,WARN,WARN,15.4,45.0,50,20.5,45.3,18.2,9.1,22.5,12.1,82.1,20,20,33.1,10.4,40.0,45.0,Yes,Unknown,4,Unknown,Not Reported,Glioblastoma_IDH1_Probe,E05,Illumina Methylation Epic v2,Illumina NovaSeq,Near Diploid,29567829,P05,8-9 servings/day,4,Not Reported,Not Reported,Unknown,250 mg,Frozen,Endometrial stromal nodule,True,Pattern 5,Floor of mouth,yes,Yes,dna-seq skip,Colonoscopy,Pediatric Oncology Initiatives,Yes,Gallbladder,Not Reported,Lung Cancer Vulnerabilities,BRCA-SEQ-21,5. Targeted Therapy for Leukemia,0.012,0.89,0.96,0.25,0.93,0.2,4,35,20,BRCA2,AALL0031,native hawaiian or other pacific islander,Yes,No,Agilent Human CpG Island Microarray,RG005_PatientC_Tumor,Properly Paired Reads,Illumina_NovaSeq_6000,200,R1,Other,Scheduling Problems,5,12.0,Not Applicable,Palliative chemotherapy,clinical_trial_results.docx,MRI_Scans,58,unspecified,Leukemia,Natural Sister,Yes,Yes,no,4,True,2023-05-25,False,True,False,RX,R1,11-20 mm,Unknown,5,20,No,1.9,6.5,Autoimmune Atrophic Chronic Gastritis,Both Clinical and Biochemical Assessments,No,Exposure to carcinogens,Long-read RNA Sequencing,6.5,Metastatic,Topical,fusion_detection.txt,5,Bone Marrow Normal,12,Pleural fluid,20,No,Unknown,Sodium Fluoride,v3.0.5,E14,KDM6A,Histone modification analysis,Pattern 5,Not Reported,Pancreas,True,False,False,True,WARN,WARN,MD Anderson Cancer Center,2022-04-05,UCLA,4.4,MSH2 mutation,PIK3CA mutations,Chromium 3' Gene Expression v3 Library,Lower limb,Brain,5,5.2,101-150 nm,Giemsa_stain_leukemia_blasts,TUNEL assay,Unknown,SomaticSniper,GATK4 Mutect2,CNVkit,SomaticSniper,PIK3CA_E545K,Tumor Mutation Burden Analysis,Mixed Adherent Suspension,Microvolume Spectrophotometry,10 nM,Lambda_Phage.fasta,34.1,Immunohistochemistry (IHC),3 Point Scale,4+,released,Sample lost during processing,Rescinded,SvABA,Insertions,False,TumorSample2_R1.fastq.gz,ALK_rearrangement_characterization,Affymetrix CytoScan HD,0.908,0.78,SRR3456789.bam,CancerQuest33_StudyE,Not Reported,Yes,Radiation Therapy,Custom SureSelect CGCI-BLGSP Panel - 4.6 Mb,CaptureMax-CM300,Ion AmpliSeq Exome Kit,Ion AmpliSeq Exome,Integrated DNA Technologies,Nextera Rapid Capture Exome Kit v1.2,Unknown,High,g/L,4.6,30-39%,Autologous Nectin-4/FAP-targeted CAR-T Cells,True,Yes,>14 mg/L,12,25,Within 5 Minutes,Not Reported,Retrospective,E5-20,External lip,Prostate,Peritumoral,False,2001,2005,6,1000000,15000,ENST00000269305.10,Present,Jaw,Brain,A081105,500,250,mg/dL,120,Not Reported,Not Reported,Four Times Daily,Induction,yes,Normalization of Tumor Markers,210,Treatment Unknown,Targeted therapy,5.0,CNS,41,No,2.4,Deep,2.1,Not Reported,Unknown,GX,Three Tier,Many,Many,4.7,5.6,Periurethral zone,5,0.55,Not Reported,Diffuse,2.0,6.0,data_release,Marijuana smoke,Pipe,M1c,N1c,Stage IIC1,T2c,M1d,N2,Stage IIA1,T1a1,5th,Yes,Yes,30,Bilateral,Testis Removed,Not Reported,Left,2023-05-19T08:30:00Z,4,Somatic,Insertion,No,No Vascular Invasion,HCV Genotype,alive,32,82.3,Abnormal nuclei,4,E05,Not Applicable,Grade Not Assigned,Not Reported,Not Reported,2023-11-02T18:30:00Z,https://github.com/clinical-genomics/workflow5/commit/u1v2w3x4y5,2023-05-25T11:15:00,GISTIC - Focal Deletion,3.0.0,1918,2019,2009,5,10,Unknown zone,Nullizygous
2.1,R175H,Not Reported,P5_Dual_Index_Adapter,AATGATACGGCGACCACCGAGATCTACAC,Dysplasia; high grade,Not Reported,Hematosalpinx,Grade 4,18250,29,45,35,True,PIK3CA mutations,Encephalopathy,MX,N1bI,Stage IIIA,T4b,MX,N1bIV,Stage IIB,T3a,6th,5.0,2.5,Weekly Drinker,yes,Occasional Drinker,Wine,sample02_normal_aligned_reads.bam,R6_90123,6. Adapter Sequence Trimming,GATK Best Practices,300,300,Bone marrow aspirate,20.0,RNA_seq_normalized_counts.tsv,5.1,RNA,S,300,CEA,Yes,Present,Trisomy,Not Reported,Night Sweats,Unknown,Not Reported,Unknown,PTEN_T102*,CD5,Sequence Read Archive (SRA),No,Crocidolite,25.3,400,200,False,No,PacBio SMRT Link,Bonito_0.4.0,Unknown,606,BCR-KL06,PR-Partial Response,Fundus Of Stomach,Unknown,HEPES Buffer,Peritoneal Fluid,1.0,2.1,400.0,31.7,2.06,Yes,2.0,Not Allowed To Collect,Screening,Leukemia,HCMI-01617,History of unacceptable prior treatment related to a prior/other malignancy,Not Cancer Related,Unknown,Targeted therapy response,610,Not Reported,25000,Community Cancer Center (ComCC),Cleveland Clinic Taussig Cancer Institute,Green,Arsenic,Yes,C,MethChip_006,F6-25,abcam ab4729 anti-H3K27ac,H3K9me3,t(6;11)(q27;q23),chr23,q,20,3.5,V,Observation,metastasis,Selenium,No,Clonal,No,DIAG-2023-06,Unknown,High Risk,Unknown,Unknown,Unknown,Heart failure,Heart Disease,Radiology,Derived Cell Line,1.0,Consent Waiver,Not Reported,0.025,0.15,Liver,5,CNV_genotyping_results.json,5,CrossMap_Tool,11,Quantitative PCR,Israel,Guam,6,2023-06-30T13:20:00Z,1614988800,Dr. Siddhartha Mukherjee,150,11p15.5,Sequencing Data,JPEG 2000,CSV,ALK rearrangement,Isoform Expression Quantification,Clinical Data,45,84,-2920,28,90,7,180,60,60,365,28,1095,-730,210,10,180,180,270,-2190,10,21,35,150,21,phs000429,Marital Status,Histological_images.zip,Lung adenocarcinoma,Oral Hypoglycemic,Leukemia,False,Yes,5,RD-Responsive Disease,Giant Cell Tumors,Unknown,DISTR-00678GB,88,10.1056/NEJMoa1809615,No,No,PARP inhibitor,No Dysplasia,Not Reported,5,Vocational College or Some College,Favorable,Spherical Particles,Illumina 1.7,Not Reported,Regional or Distant Metastasis (M1),Stage III,Extracompartmental (T2),M1,N0,Stage IV,T1,Yes,34.4,file_size,Unknown,Not Reported,unknown,Convincing Image Source,Convincing Image Source,5 or More Days,exon6,sequencing_protocol_details.pdf,DrugSensitivity_GBM8401_Temozolomide,Repli-G X,RNA Sequencing,Total RNA-Seq,Not Reported,3.0,20,Work,Marijuana,Human papillomavirus (HPV),Microarray data analysis,Not Reported,Unknown,Gross Extension,True,Unknown,Hazel,M5,Melanoma,normal_sampleB_R2.fastq,64.3,82.4,110,110,Stage IIIB,2009,Melanoma_SampleA_Panel.ppt,16384,submitted,ClinicalNotes.pdf,6,Not Reported,31-90 Days,Sensory Changes,FCB67890C1,18-month follow-up,400,450,350,38.7,MboI,Ultra-rapid freezing,Yes,not reported,PTEN_loss,MYB,ChIP-Seq Peak Calling,VarScan2,Not Reported,Pattern 5,30,5,Not Reported,5.8,110.4,72,Not Reported,183,Unknown,Unknown,Not Reported,H3.1,Not Reported,Lower Grade Glioma,0.75,Unknown,Unknown,Progesterone and Estrogen,51,HPV51,Unknown,Radical Hysterectomy,C25.9,C25.9,root,Poor Prognosis,Pancreas,2023-06-30,Not Reported,Unknown,1.9,7.8,PET,Not Reported,True,True,Sample Procurement,Refractory Disease,35.7,Unknown,Unfavorable,Unknown,Stage 4,Illumina NovaSeq X,2024-05-30,15.4,Low Risk,intron-6,Group IIc,Unknown,False,True,Not Reported,II,50,PASS,Metamyelocytes,6,Microscopic,Unknown tumor status,Unilateral,2020-02-29T18:15:55Z,2023-02-28T08:30:00Z,6,ImmunoEditDB,SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian (634413),Nextera XT DNA,Agilent Technologies,KAPA HyperPrep Kit v5.4,Random,Second_Stranded,WGS,5,20,MYC 8q24.21,15.0,Unknown,Functional (Limited) Neck Dissection,Right,NOS,Indeterminant,5,Yes,5,No,800,6,2.5,Indeterminant,Renal Sinus,Widowed,Stage IVb,CGI_6392_Unchanged,EGFR_L858R,Peri-orbital soft tissue,d3d9446802a44259755d38e6d163e820,250X,Echographic,Centimeters,WNT-Activated,Not Reported,Postmenopausal,Unknown,Regional Metastasis,Regional,Physical Exam,Pan-Procto Colectomy,Differential Methylation Analysis,0.9,Illumina Infinium Liftover,Not Reported,Unknown,6,Northern blotting,hsa-miR-146a-5p,Not Reported,Intermediate,6,950,Microarray,Non-coding Transcript Exon Variant,HER2/neu amplification,Papillary,8474/3,5.7,MSI,PCR654M3N,12,Class V,105,hg19,cruk.cam.ac.uk,12.5,Not Reported,False,True,False,True,Not Reported,Not Reported,Statin,Not Allowed To Collect,High risk of recurrence based on current data,600,6,25,600,12,Public Health Specialist,Not-Embedded-In-OCT,Ki-67 Index,Ovarian Capsule Ruptured,Not Reported,Unknown,No,Intermittent,10.0,600,2009,Type 1,Saliva sample,No,6,Pathogenic,HER2-positive breast cancer,c2e5de08-0a8e-4f77-a658-3c5d8b3c5b7f,HER2-positive breast cancer,Nephrectomy specimen with tumor that penetrates the renal capsule or involves the renal sinus with negative margins and negative lymph nodes; no distant metastasis,Not Reported,WARN,Not Reported,Not Reported,Not Reported,Not Reported,9.7,56.3,52,25.7,9.1,21.4,15.4,30.0,15.4,69.4,25,25,18.5,15.2,45.6,56.3,Unknown,4 or More,5,Unsatisfactory,Negative,Leukemia_Flt3_ITD_Run,F06,Ion Torrent,Agilent SureSelect,Not Reported,30541042,P06,10-11 servings/day,5,Spontaneous Abortion,Yes,No,300 mg,Not Allowed To Collect,Glioblastoma multiforme,False,Pattern 4,Not Applicable,no,No,dna-seq skip,Colonoscopy,Breast Cancer Awareness,no,Kidney,Regional,Melanoma Molecular Mapping,PANCR-PROJ-20,6. CAR-T Cell Therapy in Lymphomas,0.015,0.81,0.94,0.3,0.88,0.25,5,40,25,PIK3CA,AALL03B1,not allowed to collect,No,Yes,NimbleGen Human DNA Methylation 3x720K CpG Island Plus RefSeq Promoter Array,RG006_PatientC_Normal,Duplicate Reads,Illumina_MiSeq,250,R1,Withdrawal by Subject,Unknown,6,15.4,Not Reported,Maintenance chemotherapy,imaging_data.dicom,CT_Scans,65,not reported,Liver Cancer,Nephew,No,Yes,not reported,5,True,2023-06-30,False,False,False,Unknown,RX,1-10 mm,No,6,25,No,2.2,5.8,Hereditary Ovarian Cancer,Clinical Assessment,Unknown,Chronic inflammation,Ribosome Profiling (Ribo-Seq),5.8,Basal,Inhalation,methylation_profiles.csv,6,Lymphoid Normal,16,Ascites fluid,25,No,Not Reported,Sodium Fluoride,v3.1.2,E17,LYL1,Non-coding RNA analysis,Pattern 3,Unknown,Liver,False,False,True,False,Unknown,Not Reported,Mayo Clinic Genomics Core,2022-06-18,UCSF,1.7,APC mutation,PTEN loss,Chromium scATAC v1 Library,NOS,Adrenal glands,6,6.0,151-200 nm,Periodic_acid-Schiff_colorectal_cancer,Papanicolaou stain,Unknown,Lofreq,Lofreq,VarScan2,LoFreq,PTEN_T102*,Cell-Free DNA Sequencing,Mononuclear Cells from Bone Marrow,Bradford Assay,20 nM,MS2_Phage.fasta,45.5,Haemotoxylin and Eosin (H&E),3 Point Scale,3+,review,Incorrect sample labeling,Approved,BreakDancer,Copy number variations (CNVs),True,TumorSample2_R2.fastq.gz,HER2_amplification_status,Illumina HumanHap550,0.457,1.08,SRR9876543.bam,GeneMap21_TrialF,Occipital lobe,Yes,Metastasis,Custom SureSelect Human All Exon v1.1 Plus 3 Boosters,SeqPure-CTK420,Nextera Rapid Capture Exome,Nextera Rapid Capture Exome,Qiagen,Twist Human Core Exome Kit,mRNA,Intermediate,g/dL,9.9,40-49%,CDK4/6 Inhibitor BPI-16350,False,No,>14 mg/L,15,30,31-60 Minutes,Other,Prospective,F6-25,NOS,Ovary,Tumor,True,1988,2010,7,1250000,23456,NM_004333.5,Present,Lymph Node(s) Occipital,Liver,A081801,600,300,mg/day,150,Unknown,Not Reported,Once Weekly,Neoadjuvant,unknown,Persistent Disease,240,Brachytherapy,Surgery,6.3,medulloblastoma,50,No,4.9,Superficial,5.3,Premalignant,Unknown,High Grade,Three Tier,Moderate,Few,5.3,8.9,Apex,6,0.45,Unknown,Unknown,2.4,0.9,data_release,Oil burning smoke,Smokeless Tobacco,MX,N1mi,Stage IIIA,T3a,M2,N2c,Stage IIIA1,T1c2,6th,Not Reported,Not Reported,36,Left,Not Reported,Not Reported,Not Reported,2023-06-30T16:20:00Z,5,Somatic,Inversion,Not Reported,Not Reported,Hepatitis B Surface Antigen,dead,34,76.8,Diffuse architecture,5,F06,Unknown,Not Reported,Unknown,Unfavorable,2023-12-20T07:45:00Z,https://github.com/cancer-analysis/workflow6/commit/z6a7b8c9d0,2023-06-30T13:45:00,HTSeq - Counts,3.1.4,1922,2020,2010,6,15,Transition zone,Unknown
1.8,Y220C,WARN,P7_Multiplexing_Sequence,CAAGCAGAAGACGGCATACGAGAT,Epithelial hyperplasia,Yes,Optic Nerve Disorder,Grade 2,29220,34,50,40,True,PTEN mutations,Isosporiasis,Not Allowed To Collect,N1bIV,Stage IIIC,Ta,Not Allowed To Collect,N1c,Stage III,T3b,7th,6.0,3.0,Weekly Drinker,No,Social Drinker,Wine,patientB_tumor_replicate2.bam,R7_56789,7. Low Complexity Filter Application,TopHat2,350,350,Urine,50.0,DNA_methylation_profiles.parquet,0.5,Repli-G (Qiagen) DNA,T,350,HER2,Not Reported,Sclerosis,Trisomy,Not Reported,Night Sweats,Stage IV,Not Allowed To Collect,Stage III,APC_R876*,CD56,European Genome-phenome Archive (EGA),Unknown,Crocidolite,40.1,450,225,False,Unknown,BCFtools,Guppy_3.2.10,PASS,707,BCR-MN07,PSR-Pseudoresponse,Humerus,Bilateral,Sodium Pyruvate,Saliva,2.5,11.0,105.0,33.2,2.17,Not Reported,2.3,Not Reported,Surveillance,Lymphoma,HCMI-01920,Inadvertently shipped,Not Reported,Not Reported,Surgical intervention impact,400,Transfusion Recipient,30000,National Cancer Institute (NCI),Fred Hutchinson Cancer Research Center,Green,Chromium,Unknown,C11,MethChip_007,G7-30,abcam ab4729 anti-H3K27ac,Input Control,t(6;9),chr3,p,25,4.0,V,Redaction,not reported,Vitamin C,No,Clonal,Unknown,PREV-2023-07,Stage IV,Not Reported,Stage I,High Risk,Yes,Obesity,Lymphamatoid Papulosis,Histology,Lymphocytes,1.5,Consent Exemption,No,0.03,0.01,Not Reported,6,copy_number_ratios.tsv,6,LiftOver_minimap2,13,Digital PCR,Malaysia,Guatemala,7,2023-07-15T17:05:00Z,1615075200,Prof. Emmanuelle Charpentier,180,13q14.2,Sequencing Reads,JSON,TSV,BRCA1 mutation,Simple Germline Variation,Imaging Data,60,98,-5110,35,120,10,210,90,90,730,35,1460,-365,240,14,210,210,365,-2555,14,28,42,180,28,phs000430,Education Level,Radiology_images.dicom,Colorectal adenocarcinoma,Other,Lymphoma,False,Unknown,6,RP-Response,Leukemias,Distal (>2cm),DISTR-00789SC,74,10.1093/jnci/djx250,No,Not Reported,Growth factor,Not Reported,Other,Not Reported,High School Graduate or GED,Adverse,Y-90 Sirsphere,Phred+33,Unknown,Unknown,Unknown,Unknown,M1,N1,Stage IV,T4,Yes,41.8,md5sum,Not Reported,Not Reported,not hispanic or latino,Convincing Image Source,Physical Examination,5 or More Days,exon7,drug_administration_schedule.docx,Angiogenesis_HUVEC_VEGF,Total RNA,Chromatin Immunoprecipitation Sequencing (ChIP-seq),Validation,Not Reported,4.0,25,Occupational,Radiation,Hepatitis B virus (HBV),Protein expression profiling,Extensive,Unknown,No Extranodal Extension,False,Unknown,Not Reported,M6,Pancreatic cancer,patientX_pre-treatment_R1.fastq,79.8,78.8,58,99,Stage IIIC1,1995,GBM_Patient5_CNV.csv,32768,uploaded,BloodTestResults.json,7,Other,31-90 Days,Unknown,FCB78901D2,2-year follow-up,450,500,400,45.9,MboI,Controlled-rate freezing,Not Reported,not reported,BCL2_high_expression,RECQL4,MicroRNA Profiling,FreeBayes,Group 2,Pattern 5,35,4,Not Reported,6.3,95.7,84,No,145,Not Reported,Unknown,Unknown,H3.2,No,Lower Grade Glioma,1.0,Progestin,Current User,Not Reported,53,HPV52,Vagina,Simple Hysterectomy,C16.9,C16.9,root,Poor Prognosis,Prostate,2023-07-15,Retroperitoneal Lymph Node Involvement,Negative,3.3,9.0,Ultrasound,Other,False,True,Study Enrollment,Residual Disease,40.3,Poorly Differentiated,Unknown,Not Reported,Stage 4S,Ion Torrent PGM,2024-08-15,18.6,High-Intermediate Risk,intron-7,Group IV,3,False,True,Unknown,Not Reported,70,PASS,Promyelocytes,7,Macroscopic (2cm or less),With tumor,Unknown,2021-04-14T07:46:10Z,2021-04-18T12:05:00Z,7,CancerStemCellNet,TruSeq Stranded mRNA Library Prep (20020594),TruSeq DNA PCR-Free,Takara Bio,SureSelectXT Human All Exon v7,miRNA Size Fractionation,Second_Stranded,WXS,6,25,CDKN2A 9p21.3,17.8,Unknown,Functional (Limited) Neck Dissection,NOS,Iliac-external,Negative,6,Not Reported,6,No,1000,7,3.0,Not Reported,Renal Vein,Domestic Partnership,Stage IVb,CGI_7450_Hypermethylated,APC_R876*,Pericardium,6512bd43d9caa6e02c990b0a82652dca,300X,Radiologic,Centimeters,Not Determined,No,Postmenopausal,No,Unknown,Pleura,Surgical Resection,Partial Maxillectomy,Replicate Handling Strategy,0.3,RRBS to GRCh38,Not Reported,Present,7,droplet digital PCR (ddPCR),hsa-miR-10b-5p,Not Reported,Not Reported,7,1700,Microsatellite Analysis,Splice Acceptor Variant,PIK3CA mutation analysis,NOS,8504/3,6.3,MSS,LBR852W4K,12,Class III,123,junction,vanderbilt.edu,15.2,Not Reported,False,False,False,False,Not Reported,Unknown,Statin,Unknown,Patient enrolled in clinical trial for new therapy,700,8,30,750,15,Biomedical Engineer,OCT-Compound-Used,Tumor Infiltrating Lymphocytes,Not Reported,Indeterminate,PASS,Yes,Intermittent,15.0,90,2011,Type 1,Cerebrospinal fluid,Not Reported,7,Uncertain Significance,Follicular lymphoma,d8f5e2b4-1e4c-4aaf-9f8c-7a9e5985b8f0,Follicular lymphoma,Not Reported,PASS,PASS,Not Reported,Not Reported,PASS,Not Reported,3.2,67.1,55,30.1,15.4,25.7,3.2,37.2,18.6,55.8,30,30,9.7,20.0,51.3,67.8,Not Reported,0,6,Atypical,Negative,PancreaticCancer_CDKN2A_Set,G07,LS454,10x Genomics Chromium,Tetraploid,31298756,P07,12-13 servings/day,6,Stillbirth,Yes,Unknown,350 mg,Not Reported,Jadassohn blue nevus,False,Pattern 1,Other and unspecified female genital organs,Not Allowed To Collect,No,dna-seq skip,Unknown,Lung Cancer Research,not reported,NOS,Unknown,Pancreatic Cancer Early Detection,GLIO-GS-19,7. Biomarkers for Prostate Cancer Prognosis,0.018,0.98,0.97,0.35,0.9,0.3,6,45,30,PTEN,AAML0631,not reported,Yes,Not Reported,SurePrint G3 Human CGH Microarray,RG007_PatientD_Tumor,Average Read Length,Ion_Torrent_S5,300,R1,Death,Not Done per Treating Physician's Discretion,7,18.2,Proton Pump Inhibitors,Hormonal therapy,pathology_reports.zip,PET_Scans,48,unknown,Lymphoma,Sibling,No,No,yes,6,True,2023-07-15,False,False,False,R1,RX,No macroscopic disease,Unknown,7,30,No,1.6,4.9,Neurocystericerosis,Both Clinical and Biochemical Assessments,No,Age over 65,Small RNA-Seq,4.9,Squamous,Intraperitoneal,copy_number_variation.bed,7,Neoplasms of Uncertain and Unknown Behavior,17,Cerebrospinal fluid,30,No,Absent,Sodium Fluoride,v4.0.0,E20,PHF6,Single-cell RNA sequencing,Pattern 1,No,Stomach,False,True,True,True,Unknown,Not Reported,Memorial Sloan Kettering Cancer Center,2022-09-09,MGH,2.9,PTEN mutation,CDKN2A inactivation,Chromium 3' Gene Expression v3 Library,Supraglottis,Peritoneum,7,0.9,201-250 nm,Oil_Red_O_stain_liposarcoma,Giemsa stain,Unknown,Platypus,Shimmer,CopywriteR,Pindel,APC_R876*,Protein Truncation Test,Plasma,BCA Protein Assay,50 nM,SpikeIn_VirusMix.fasta,16.7,Immunohistochemistry (IHC),3 Point Scale,1+,submitted,Equipment malfunction during analysis,Approved,VarScan2,Tandem duplications,True,NormalSample2_R1.fastq.gz,PIK3CA_mutation_spectrum,Thermo Fisher OncoScan,0.289,0.99,SRR4567890.bam,MolecuCare55_ProjectG,Parietal lobe,Unknown,Angiogenesis,Custom Twist Broad PanCancer Panel - 396 Genes,TargetFlex-TF500,Twist Human Core Exome,Twist Human Core Exome,Oxford Gene Technology,Ion AmpliSeq Exome Kit v5,miRNA,Mitotic Count Reported,mg/24 hr,1.2,51-75,Cetuximab,True,Unknown,>14 mg/L,18,35,31-60 Minutes,Post Hormone Therapy,Retrospective,G7-30,Gallbladder,Liver,Unknown,False,1975,2012,Current Reformed Smoker for < or = 15 yrs,1500000,4096,NM_002524.5,Absent,Nails,Pancreas,E4512,700,350,mg/kg,180,Incomplete Necrosis (Viable Tumor Present),Not Reported,Once a Week for at Least a Year,Not Reported,unknown,Treatment Ongoing,270,Low Dose,Stem cell transplant,7.1,CNS,51,Unknown,8.3,Not Reported,6.0,Primary,Not Reported,Intermediate Grade,Four Tier,Few,Few,6.0,1.2,Base,7,0.35,1,Unknown,2.8,5.4,data_release,NOS,Cigar,Not Reported,N2b,Stage IIIB,T3d,MX,N2mi,Stage IIIC2,T2b,7th,Yes,Not Reported,42,Right,Spontaneous Descent,Yes,Bilateral,2023-07-14T10:10:00Z,6,Somatic,Loss,Not Reported,Unknown,Hepatitis C Antibody,lost to follow-up,36,63.7,Necrosis,6,G07,Not Applicable,Unknown,GX,Not Reported,2024-01-15T13:30:00Z,https://github.com/molecular-diagnostics/workflow7/commit/e1f2g3h4i5,2023-07-22T10:00:00,Pindel Variant Aggregation and Masking,4.0.0,1926,2021,2011,7,20,Transition zone,Hemizygous
1.75,D816V,Not Reported,MiSeq_Adapter,GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT,Keratinizing dysplasia; severe (carcinoma in situ),No,Scalp Pain,Grade 2,6570,41,55,45,False,CDKN2A mutations,Mycobacterium,Not Reported,N1c,Stage IV,Tis (DCIS),Not Reported,N2b,Stage IIIA,T4c,8th,7.0,3.5,Weekly Drinker,no,Unknown,Wine,patientB_normal_replicate2.bam,R8_01234,8. Chimera Sequence Identification,SOAPaligner,400,400,Saliva,75.0,protein_expression_levels.dat,2.0,Repli-G Pooled (Qiagen) DNA,W,400,PD-L1,Yes,Unknown,Trisomy,Not Reported,Fever,Not Reported,Unknown,Stage I,ALK_E1202K,CD7,dbGaP (Database of Genotypes and Phenotypes),Unknown,Crocidolite,32.6,500,250,False,No,FreeBayes,Albacore_1.2.1,Unknown,808,BCR-OP08,RD-Responsive Disease,Lymph Node(s) Supraclavicular,Bilateral,Non-Essential Amino Acids,Serum,0.75,4.2,1.3,26.4,2.28,Yes,2.5,Sporadic,Surveillance,Bladder cancer,HCMI-02223,Normal tissue origin incorrect,Renal Disorder,Autopsy,Spontaneous regression,230,Unknown,35000,Integrated Cancer Center (ICC),UCSF Helen Diller Family Comprehensive Cancer Center,Green,Nickel,Unknown,C12,MethChip_008,H8-35,abcam ab4729 anti-H3K27ac,Unknown,t(8;21),chr4,Not Reported,30,4.5,V,Downstream Data Freeze,other,Coenzyme Q10,No,Clonal,Yes,MOL-2023-08,Stage II,Not Reported,Stage IV,Low Risk,Yes,Osteoporosis,Peutz-Jeghers Disease,Radiology,Plasma,2.0,Consent Waiver,No,0.035,0.04,Small Bowel,7,CNV_calling_parameters.yaml,7,DELLY2_Liftover,15,Breakpoint Analysis,Serbia,Jersey,8,2023-08-20T10:10:00Z,1615161600,Prof. Jennifer Doudna,220,15q11.2,Simple Nucleotide Variation,SRA XML,HDF5,BRCA2 mutation,Splice Junction Quantification,Pathology Data,75,112,-17520,42,150,14,240,120,120,1095,42,1825,-180,270,21,240,240,400,-2920,21,35,56,210,35,phs000431,Employment Status,Clinical_data.xml,Ovarian serous carcinoma,Sulfonylurea,Bladder cancer,False,Unknown,7,TE-Too Early,NOS,Not Reported,DISTR-00890OC,110,10.1002/cncr.30888,No,Not Reported,PARP inhibitor,Severe,Unknown,Unknown,Professional or Graduate Degree,Unknown,Y-90 Therasphere,Phred+64,Not Reported,Regional or Distant Metastasis (M1),Stage IA,Unknown,M0,N0,Stage IV,T2,Unknown,45.3,md5sum,Negative/ No Dysplasia,Not Reported,not hispanic or latino,Histologic Confirmation,Physical Examination,5 or More Days,exon8,histological_analysis_procedure.txt,DNARepair_U2OS_Radiation,aDNA Preparation Type,Flow Cytometry,WXS,Unknown,5.0,30,Occupational,Radon,Hepatitis C virus (HCV),Chromatin immunoprecipitation sequencing (ChIP-seq) analysis,Extensive,No,No Extranodal Extension,True,Unknown,Other,M7,Leukemia,patientX_pre-treatment_R2.fastq,72.6,69.5,95,45,Stage IV,1988,Healthy_Control_DNA.maf,65536,uploading,ProteinExpression_proteomics.csv,8,Progression,31-90 Days,Visual Changes,FCB89012E3,3-year follow-up,500,550,450,50.2,MboI,Direct plunging,Not Reported,female,MYC_oncogene_activation,ROBO2,Single-Cell RNA-Seq Clustering,Platypus,Group 2,Pattern 4,40,3,No,7.0,60.8,96,Not Reported,155,Unknown,Anaplastic,H2B,H3.X,No,Lower Grade Glioma,1.5,Not Reported,Former User,Unknown,59,HPV66,Not Reported,Unknown,C81.9,C81.2,root,Good Prognosis,Ovary,2023-08-09,Vena Cava Involvement/Thrombus,Positive,7.4,10.4,PET,Unknown,True,True,Sample Procurement,Unknown,50.6,Poorly Differentiated,Unfavorable,L1,Unknown,Ion Torrent Proton,2024-10-22,21.9,Low Risk,intron-8,Group Ia,3,True,True,6 - Established Cirrhosis,Not Reported,80,PASS,Serum Mesothelin,8,Macroscopic (greater than 2cm),not reported,Unknown,2022-08-23T13:27:05Z,2022-05-25T14:50:00Z,8,CancerViroLib,NEBNext Ultra RNA Library Prep Kit for Illumina (E7530),Ion AmpliSeq Library Kit,Bio-Rad Laboratories,Ion AmpliSeq Library Kit 2.0,rRNA Depletion,Second_Stranded,m6A MeRIP-Seq,7,30,PTEN 10q23.31,20.4,Yes,Radical Neck Dissection,Neck,Pelvis,Unknown,7,Not Reported,7,No,1200,8,4.0,Involved,Ureter,Married,Stage IIb,CGI_8532_Hypomethylated,CDKN2A_W110*,Soft tissue (muscle,c20ad4d76fe97759aa27a0c99bff6710,350X,Radiologic,Centimeters,Not Determined,Yes,Postmenopausal,Unknown,Not Reported,Retroperitoneum,Thoracentesis,Subtotal Prostatectomy,Quality Masking of Unreliable Probes,0.75,CGmap to Bismark Liftover,Not Reported,Unknown,8,RNA immunoprecipitation sequencing (RIP-seq),hsa-miR-221-3p,Not Reported,Intermediate,8,2100,Microscopy,Stop Lost,MSI testing (Microsatellite Instability),Solid,8727/0,7.0,MSI,DNA963R5J,12,Class III,145,lowess_normalized_smoothed,ucsf.edu,18.6,Not Reported,False,False,False,True,Unknown,Unknown,Statin,Not Allowed To Collect,Immunohistochemistry suggests high proliferation index,800,10,33,900,18,Radiologic Technologist,OCT-Compound-Not-Used,PD-L1 Expression,Not Reported,Not Reported,FAIL,No,Intermittent,20.0,240,2013,Type 1,Urine sample,No,8,Uncertain Significance,Hodgkin's lymphoma,e4a3bc1f-7b2e-46d7-a257-3e8d99d6f5ab,Hodgkin's lymphoma,Tumor biopsied only at diagnosis; distant metastasis identified at diagnosis,Unknown,Unknown,Not Reported,PASS,Not Reported,Unknown,5.6,72.8,57,35.4,28.7,29.9,11.7,45.0,20.0,49.6,35,35,26.3,25.5,58.8,70.4,Unknown,4 or More,7,Atypical,Not Reported,BreastCancer_HER2_Overlay,H08,Other,PacBio Sequel,Unknown,32098765,P08,14-15 servings/day,7,Unknown,Yes,Unknown,400 mg,OCT,Malignant lymphomatous polyposis,True,Pattern 2,Skin,yes,Not Reported,dna-seq skip,Unknown,Prostate Cancer Studies,unknown,Lesser curvature of stomach,Not Reported,Prostate Cancer Risk Factors,LEUK-2023-STUDY,8. Ovarian Cancer Risk Assessment Models,0.02,0.73,0.93,0.4,0.94,0.35,7,50,35,ALK,ADVL0215,other,Yes,No,Illumina Infinium MouseMethylation450K,RG008_PatientD_Normal,GC Content,PacBio_Sequel,350,R3,Adverse Event,Scheduling Problems,8,21.5,Surgically Treated,Immunotherapy,pharmacogenomics_data.tsv,Blood_Test_Results,31,unspecified,Rectal Cancer,Son,Yes,Not Reported,no,7,True,2023-08-20,True,True,True,R2,R0,No macroscopic disease,Unknown,8,35,No,1.7,4.2,Rheumatoid Arthritis,Clinical Assessment,No,High-fat diet,Differential Gene Expression Analysis,4.2,Adenomatous,Intravesical,histone_modification.bedgraph,8,Not Allowed To Collect,31,Urine,35,No,Not Reported,Sodium Fluoride,v4.4.4,E23,PML,Phosphoproteomics,Pattern 5,Not Reported,Esophagus,False,True,False,True,PASS,Not Reported,Wellcome Sanger Institute,2022-12-01,NCI,5.1,ATM mutation,APC mutations,Chromium 3' Gene Expression v3 Library,Thymus,Skin,8,7.3,251-300 nm,Wright_stain_myeloma_cells,Immunohistochemistry,Every day,DeepVariant,Varscan2 SNP,BIC-seq2,DeepVariant,CTNNB1_S45F,Loss of Heterozygosity Analysis,Serum,Lowry Assay,100 nM,Arabidopsis_lyrata_SpikeIns.fasta,29.3,Haemotoxylin and Eosin (H&E),4 Point Scale,2+,uploaded,Sample degradation detected,Approved,Pindel,Interchromosomal rearrangements,True,NormalSample2_R2.fastq.gz,PD-L1_expression_quantification,Illumina Global Screening Array,0.631,1.2,SRR0987654.bam,NeoGrowth88_ResearchH,Spinal Cord,Not Reported,Carcinogenesis,Nextera DNA Exome,GeneGuide-GGK700,Roche SeqCap EZ MedExome,Roche SeqCap EZ MedExome,BGI,xGen Exome Research Panel v1.5,mRNA,Normal,mg/L,3.4,76-100,Fc-engineered Anti-CD40 Agonist Antibody 2141-V11,True,Yes,>14 mg/L,21,40,Within 5 Minutes,Preoperative,Prospective,H8-35,Ill-defined sites within respiratory system,Skin,Unknown,False,1990,2014,Current Smoker,1750000,8192,ENST00000445888.7,Unknown,Penis,Ovary,A081801,800,400,mg/m2,210,No Necrosis,Not Reported,Twice Daily,Prevention,yes,Treatment Stopped Due to Toxicity,300,I-131 Radiation Therapy,Cryotherapy,8.5,other,52,Not Reported,5.1,Superficial,7.8,Recurrence,Unifocal,Low Grade,Four Tier,Many,Many,7.2,9.4,Mid gland,8,0.25,Not Reported,Unknown,3.1,7.2,data_release,Tobacco smoke,Electronic Cigarette,Unknown,N2c,Stage IIIC,T4,Not Reported,N3,Stage IV,T3c,8th,Not Reported,Yes,48,Left,Spontaneous Descent,Not Reported,Bilateral,2023-08-05T18:50:00Z,7,Unknown,Repeated Sequences,No,Extramural,Hepatitis C Virus RNA,dead,37,89.0,Venous invasion,7,H08,Unknown,Grade II,G2,Unfavorable,2024-02-25T10:15:00Z,https://github.com/cancer-therapy/workflow8/commit/j6k7l8m9n0,2023-08-18T15:30:00,Read Group Quality Control,4.2.0,1930,2022,2012,8,25,Transition zone,Unknown
2.15,KIT_D816V,FAIL,HiSeq_X_Ten_Adapter,AGATCGGAAGAGCGGTTCAGCAGGAATGCCGAG,Other Complex Extravascular Matrix Patterns,Yes,Skin and Subcutaneous Tissue Disorders - Other,Grade 4,9490,47,60,50,False,RB1 mutations,NOS,Unknown,N3c,Stage IVB,Tis (LCIS),Unknown,N3a,Stage IVB,TX,Not Reported,0.5,4.0,Weekly Drinker,Not Reported,Unknown,Liquor,primary_tumor_03.bam,R9_67890,9. rRNA Sequence Depletion,MAQ,450,450,Cerebrospinal fluid (CSF),100.0,clinical_trial_annotations.pdf,4.5,Repli-G X (Qiagen) DNA,X,450,BCR-ABL,Yes,Present,Trisomy,Not Reported,Other,Stage IV,Not Reported,Stage IV,HER2_S310F,Immunoglobulin,Protein Data Bank (PDB),Unknown,Amosite,27.8,550,275,False,No,Strelka2,Bonito_0.2.5,Unknown,909,BCR-QR09,SD-Stable Disease,Paranasal Sinuses,Left,Insulin-Transferrin-Selenium,Unknown,3.5,13.5,50.0,28.8,2.39,No,3.0,adult,Screening,Pancreatic cancer,HCMI-02526,Qualification metrics changed,NOS,Death Certificate,Infection-related response,670,Hemophiliac,40000,Regional Cancer Center (RCC),Stanford Cancer Institute,Green,Cadmium,Yes,Not Reported,MethChip_009,I9-40,abcam ab4729 anti-H3K27ac,H3K27me3,t(9;11)(p22;q23),chr8,p,40,5.0,V,Complete Data Freeze,primary,Melatonin,No,Clonal,Yes,BIO-2023-09,Stage IV,Low Risk,Stage IV,Unknown,Unknown,Anemia,Renal Failure (Requiring Dialysis),Not Reported,Solid Tissue,2.5,Informed Consent,No,0.04,0.06,Spleen,8,sample_annotation_metadata.xml,8,BIC-seq2_Liftover,17,Fluorescence In Situ Hybridization,State of Palestine,Kiribati,9,2023-09-05T15:50:00Z,1615248000,Dr. Harold Varmus,250,17p13.1,Somatic Structural Variation,TARGZ,XML,PD-L1 expression,Structural Alteration,Pharmacogenomic Data,90,126,-2190,60,180,21,270,150,150,1460,60,2190,-90,365,28,270,270,500,-3285,28,42,70,240,42,phs000432,Insurance Status,Pathology_reports.pdf,Pancreatic ductal adenocarcinoma,Thiazolidinedione,Ovarian cancer,False,Unknown,8,Unknown,Lipomatous Neoplasms,Adjacent (< or = 2cm),DISTR-00901CC,96,10.1186/s13045-019-0768-2,No,Yes,PARP inhibitor,Unknown,Keratinizing,Unknown,Professional or Graduate Degree,Unknown,PVA Particles,ASCII-33,Not Reported,Unknown,Stage IIA,Unknown,M1,N1,Stage IV,T4,Unknown,50.0,file_size,Not Reported,Yes,not allowed to collect,Convincing Image Source,Convincing Image Source,3 to 4 Days,exon9,imaging_techniques_overview.pdf,ProteinStability_SKBR3_Herceptin,mirVana (Allprep DNA) RNA,Immunofluorescence,miRNA-Seq,Six Weeks or More,6.0,35,Home,Respirable Crystalline Silica,Processed meat,Whole genome sequencing (WGS) analysis,Extensive,Unknown,Gross Extension,True,Moderate/Advanced (T4a),Red & Violet,Not Classified,Non-Hodgkin lymphoma,patientY_post-treatment_R1.fastq,85.0,75.2,82,76,Stage IVB,1995,ProstateCancer_Sample8_RPPA.txt,131072,validated,RadiomicsFeatures.csv,9,Relapse,0-30 Days,Not Reported,FCB90123F4,5-year follow-up,550,600,500,55.6,MboI,High-pressure freezing,Unknown,unspecified,CDKN2A_inactivation,RPS15,Proteogenomics Integration,BCFtools,Group 4,Pattern 4,45,2,Not Reported,8.2,205.1,108,No,170,No,Unknown,H2A,Unknown,No,Lower Grade Glioma,2.0,Unknown,Unknown,Not Reported,68,HPV68,Vagina,Not Performed,C92.0,C92.0,root,Good Prognosis,Kidney,2023-09-22,Retroperitoneal Lymph Node Involvement,Not Performed,2.2,12.3,CT Scan,,False,True,Initial Genomic Sequencing,Residual Disease,65.9,Poorly Differentiated,Unknown,L2,Stage 2B,Ion Torrent S5,2025-02-12,24.2,High-Intermediate Risk,intron-9,Group Ib,3,True,True,0 - No Fibrosis,Unknown,90,PASS,TAG-72,9,Unknown,Unknown tumor status,Unilateral,2023-06-05T19:08:40Z,2023-03-10T15:25:00Z,9,OncolyticVirusBank,KAPA RNA HyperPrep Kit with RiboErase (HMR8455),SureSelectXT Target Enrichment,PacBio (Pacific Biosciences),TruSeq DNA PCR-Free Library Prep Kit v1,Other,Second_Stranded,scATAC-Seq,8,40,RB1 13q14.2,23.1,Yes,Functional (Limited) Neck Dissection,Neck,NOS,Negative,8,No,8,Unknown,1500,9,5.0,Indeterminant,Renal Vein,Divorced,Stage IIb,CGI_9691_Unchanged,NRAS_Q61R,ligaments,c51ce410c124a10e0db5e4b97fc2af39,400X,Pathologic,Centimeters,SHH-Activated,No,Postmenopausal,Unknown,Unknown,Spinal Cord,Ultrasound Guided Biopsy,Supraglottic Laryngectomy,Chromosomal Location Adjustment,0.6,Methylation450K Array Update,Not Reported,Present,9,small RNA cloning,hsa-miR-222-3p,Not Reported,Low,9,1900,NOS,Stop Retained Variant,TMB testing (Tumor Mutational Burden),Tubular,8770/0,8.5,MSI,MBC147Q6P,12,Class IV,167,original,hopkinsmedicine.org,21.0,Not Reported,False,False,True,False,Unknown,Unknown,Aspirin,Yes,Radiology report indicates tumor size reduction,900,12,35,1050,20,Oncology Nurse,Sample-OCT-Embedded,MSI Status (Microsatellite Instability),Ovarian Capsule Ruptured,Unknown,FAIL,Yes,Intermittent,25.0,330,2015,Type 1,Ascites fluid,Yes,9,Benign,Non-Hodgkin's lymphoma,f1d2c3b4-5e6f-7a8b-9c0d-1e2f3a4b5c6d,Non-Hodgkin's lymphoma,Tumor biopsied only at diagnosis; no distant metastasis,Unknown,WARN,FAIL,Not Reported,FAIL,Not Reported,11.1,80.4,60,40.0,56.2,33.3,6.5,50.5,23.5,33.7,40,40,40.0,30.3,63.4,82.1,No,4 or More,8,Atypical,Negative,OvarianSerous_Tumor_Plate,I09,PacBio,Illumina MiSeq,Near Diploid,33289765,P09,16-17 servings/day,8,Ectopic Pregnancy,Yes,Yes,450 mg,Snap Frozen,Medulloblastoma,True,Pattern 4,Ureter,unknown,Not Reported,dna-seq skip,Unknown,Leukemia and Lymphoma Research,yes,NOS,Biochemical,Leukemia Cell Resistance,SKIN-CANCER-18,9. Colorectal Cancer Prevention Strategies,0.023,0.85,0.91,0.45,0.85,0.4,8,55,40,KRAS,ANBL0322,unknown,Yes,Not Reported,Affymetrix Human Promoter 1.0R Array,RG009_PatientE_Tumor,Median Insert Size,Illumina_GAIIx,400,R1,Adverse Event,Scheduling Problems,9,24.7,Unknown,Targeted therapy,survival_analysis.R,Genetic_Mutation_Analysis,39,male,Tonsillar Cancer,Twin Sibling,Yes,No,not reported,8,True,2023-09-05,True,True,True,R1,R0,11-20 mm,Unknown,9,40,No,2.3,3.6,Tuberculosis,Both Clinical and Biochemical Assessments,Not Reported,Physical inactivity,RNA Immunoprecipitation Sequencing (RIP-Seq),3.6,Fibrous,Transdermal,splicing_events.sam,9,Pleural Effusion,32,Stool,40,No,Indeterminate,Sodium Fluoride,v5.0.1,E26,SS18,Glycomics,Pattern 5,No,Bladder,False,True,True,False,Unknown,WARN,Beijing Genomics Institute,2023-02-14,FHCRC,0.5,CHEK2 mutation,MET amplifications,Chromium 3' Gene Expression v3 Library,Transverse colon,Pleura,9,8.8,301-350 nm,Silver_stain_neuroendocrine_tumor,Fluorescent in situ hybridization (FISH),Some days,Pindel,Varscan2 Indel,Control-FREEC,Platypus,ALK_E1202K,Gene Expression Profiling,Solid Tissue,Biophotometer,200 nM,Yeast_tRNA_Spike.fasta,38.6,Immunohistochemistry (IHC),3 Point Scale,3+,uploading,Incomplete patient data,Approved,CNVnator,Intrachromosomal rearrangements,False,MetastasisSample1_R1.fastq.gz,NTRK_gene_fusion_identification,Affymetrix GeneChip Human Mapping 250K Array,0.774,0.88,SRR5678901.bam,OncoGen12_StudyI,Temporal lobe,No,Precision Medicine,SureSelect Human All Exon v4,PureSeq-9000TC,Agilent SureSelect Clinical Research Exome,Agilent SureSelect Clinical Research Exome,Twist Bioscience,NEBNext Direct Cancer HotSpot Panel v2.1,mRNA,Not Amplified,mg/dL,8.7,<1%,Fosgemcitabine Palabenamide,True,No,>14 mg/L,24,45,31-60 Minutes,Prior to Treatment,Prospective,I9-40,Not Reported,Kidney,Unknown,True,2005,2016,Not Reported,2000000,16384,NM_000059.4,Absent,Popliteal Fossa,Skin,A081801,900,450,mg/mL,240,No Necrosis,Not Reported,Twice Weekly,Radiation Boost,unknown,Unknown,330,Immunotherapy (Including Vaccines),Hyperthermia,9.9,NHL,60,No,7.6,Superficial,1.5,Unknown,Unknown,Not Reported,Four Tier,Few,Few,8.8,6.7,Anterior horn,9,0.15,Unknown,Unknown,3.5,2.1,data_release,cigar,Pipe,cM0 (i+),N3c,Stage IVB,T4e,Unknown,N3b,Stage IVB,T4,Not Reported,Not Reported,Yes,54,Right,Hormones,Yes,Left,2023-09-21T13:35:00Z,8,Unknown,Substitution,No,Macro,Not Reported,lost to follow-up,38,94.5,Sinusoidal invasion,8,I09,10x-25x,Grade I,G2,Favorable,2024-03-30T19:00:00Z,https://github.com/genomic-data-analysis/workflow9/commit/o1p2q3r4s5,2023-09-05T09:00:00,STAR - Counts,5.0.0,1934,2023,2013,9,30,Transition zone,Nullizygous
2.2,C797S,Not Reported,NovaSeq_6000_Adapter,CGACAGGTTCAGAGTTCTACAGTCCGACGATC,Platinum-resistant,Not Reported,Spermatic Cord Hemorrhage,Grade 4,12775,53,65,55,True,ALK mutations,Salmonella Septicemia,cM0 (i+),NX,Stage X,Tis (Paget's),cM0 (i+),N4,Stage IVC,Tis (DCIS),Unknown,1.5,4.5,Weekly Drinker,Yes,Non-Drinker,Liquor,metastasis_sample_03.bam,R10_12345,10. Mitochondrial DNA Exclusion,CRAC,500,500,Pleural effusion,150.0,imaging_features_extracted.zip,1.8,m6A Enriched RNA,Y,500,EGFR,No,Focal,Trisomy,Not Reported,Night Sweats,Stage IV,Unknown,Not Reported,NRAS_Q61R,Cytoplasmic,Human Protein Atlas,Not Reported,Amosite,34.5,600,300,True,No,LoFreq,Guppy_4.2.2,Not Reported,1010,BCR-ST10,TE-Too Early,Testis,Left,B-27 Supplement,Urine,5.0,40.0,250.0,30.5,2.5,Not Reported,3.5,Sporadic,Surveillance,Kidney cancer,HCMI-02829,Tumor class but appears normal,Surgical Complications,Death Certificate,Environmental factor influence,510,Hemophiliac,45000,Cancer Treatment Center (CTC),University of Chicago Medicine Comprehensive Cancer Center,Green,Radon,Not Reported,Unknown,MethChip_010,J10-45,abcam ab4729 anti-H3K27ac,Input Control,t(9;11)(p22;q23),chr9,p,50,5.5,III,Observation,recurrence,Ginger Extract,No,Clonal,Unknown,DATA-2023-10,Stage IV,High Risk,Stage IV,High Risk,Unknown,Depression,Sarcoidosis,Radiology,Unknown,3.0,Consent Exemption,Not Reported,0.045,0.08,Spleen,9,CNV_validation_assays.docx,9,CNVer_Liftover,19,Single-Cell Sequencing Analysis,Sweden,Saudi Arabia,10,2023-10-10T12:00:00Z,1615334400,Dr. Bert Vogelstein,300,19q13.4,Structural Variation,TIFF,JSON,MSI-High,Unaligned Reads,Immune Response Data,105,140,-8030,75,210,28,300,180,180,1825,75,2555,0,400,35,300,300,600,-3650,35,50,84,270,60,phs000433,Family History of Cancer,Survival_data.csv,Hepatocellular carcinoma,Unknown,Thyroid cancer,True,Not Reported,9,WT-With Tumor,Mature B-Cell Lymphomas,Not Reported,DISTR-01011BL,67,10.1038/s41591-019-0508-4,No,Not Reported,PARP inhibitor,Indefinite,Keratinizing,4,High School Graduate or GED,Intermediate,Lipiodol,ASCII-64,Not Reported,Regional or Distant Metastasis (M1),Stage III,Extracompartmental (T2),M1,N0,Stage II,T2,Yes,55.6,file_size,Low Grade Dysplasia,Not Reported,Unknown,Convincing Image Source,Physical Examination,5 or More Days,exon10,statistical_analysis_plan.docx,Metabolomics_HepG2_Sorafenib,nRNA - Melanoma Protocol,Tissue Microarrays,scATAC-Seq,Not Reported,7.0,40,Occupational,Smoke,Air pollution,Metabolomic profiling,Extensive,Unknown,Gross Extension,True,Unknown,Gray,M1,Thyroid cancer,patientY_post-treatment_R2.fastq,67.5,81.6,120,88,Unknown,1988,BreastCancer_Patient9_FISH.jpeg,262144,validating,ChemotherapyResponse.docx,10,Second Malignant Neoplasm,0-30 Days,Sensory Changes,FCB01234G5,Recurrence detected,600,650,550,49.1,MboI,Pellet freezing,Not Reported,unspecified,PIK3CA_mutated,ZNF198,Structural Variant Annotation,Sentieon DNAseq,Group 2,Pattern 5,50,11,No,9.4,175.0,120,No,178,Not Reported,Poorly differentiated,H2A,mH2A,Not Reported,Lower Grade Glioma,2.5,Progestin,Current User,Estrogen only,Other,HPV73,,Hysterectomy,C56,C56.9,root,Poor Prognosis,Thyroid,2023-10-13,Carcinomatosis,Not Reported,4.9,8.6,CT Scan,,True,False,Study Enrollment,Unknown,70.0,Unknown,Not Reported,Not Reported,Stage 4,Unknown,2025-04-07,27.5,Low Risk,intron-10,Not Reported,3,True,True,0 - No Fibrosis,Unknown,Unknown,PASS,Total Protein,10,Unknown,Loco-regional recurrence/progression,Bilateral,2014-09-17T20:50:25Z,2021-08-30T17:45:00Z,10,NeoantigenRepo,Agilent SureSelectXT Human All Exon V6 (5190-8863),NEBNext Ultra RNA Library Prep,Oxford Nanopore Technologies,NEBNext Ultra DNA Library Prep Kit for Illumina v2.1,Other,Second_Stranded,scRNA-Seq,9,50,HER2 17q12,25.5,Yes,Functional (Limited) Neck Dissection,Left,Retroperitoneal,Not Reported,9,Yes,9,Not Reported,2000,10,6.0,Involved,Renal Vein,Married,Stage I,CGI_10785_Hypermethylated,ALK_E1202K,subcutaneous),aab3238922bcc25a6f606eb525ffdc56,450X,Echographic,Centimeters,Non-WNT/non-SHH Activated,No,Unknown,Unknown,Distant Metastasis,Urethra,Unknown,Tumor Resection,Statistical Noise Reduction,0.25,Nanopore Methylation to hg19,Not Reported,Not Reported,10,Locked Nucleic Acid (LNA)-based assays,hsa-miR-17-5p,Not Reported,Not Reported,10,2200,Not Reported,TFBS Amplification,NTRK gene fusion,Solid,9320/0,9.2,MSI,XBS258E7L,12,Class V,190,segmented,fredhutch.org,23.4,No,False,False,False,True,Not Reported,Unknown,Acetaminophen,Not Reported,Patient reports significant improvement in symptoms,1000,15,37,1250,23,Clinical Data Manager,Sample-Not-OCT-Embedded,ECOG Performance Status,Not Reported,Present,Not Reported,Unknown,Intermittent,30.0,210,2017,Type 1,Skin biopsy,No,10,Benign,Squamous cell carcinoma,g2h3i4j5-k6l7-m8n9-o0p1-q2r3s4t5u6v7,Melanoma,Nephrectomy specimen with tumor that penetrates the renal capsule or involves the renal sinus with negative margins and negative lymph nodes; distant metastasis identified at diagnosis,PASS,PASS,Not Reported,Unknown,FAIL,PASS,8.4,85.9,62,45.2,3.5,37.5,8.9,60.0,26.8,25.4,45,45,15.6,40.0,69.1,89.6,Unknown,0,9,Unsatisfactory,Positive,ProstateCancer_AR_Splice,J10,RPPA,Roche 454 GS FLX,Not Reported,34567892,P10,18-19 servings/day,9,Not Reported,Yes,No,500 mg,Unknown,classic,False,Pattern 4,Vulva,yes,Not Allowed To Collect,dna-seq skip,Endoscopy,Cancer Prevention and Education,Not Allowed To Collect,Lymph nodes of head,Biochemical,Glioblastoma Therapeutic Approaches,PROST-DETECT-17,10. Pediatric Oncology Treatment Innovations,0.025,0.9,0.9,0.5,0.91,0.45,9,60,45,PDGFRA,CCG2961,white,Unknown,No,NimbleGen Mouse DNA Methylation 385K CpG Island Array,RG010_PatientE_Normal,Read Group Coverage,Oxford_Nanopore_GridION,450,R1,Other,Scheduling Problems,10,28.9,Not Applicable,Radiation therapy,biomarker_identification.sql,Treatment_Response_Data,55,male,Wilms Tumor,Unrelated,No,Yes,no,9,False,2023-10-10,True,True,True,R1,RX,No macroscopic disease,No,10,45,No,1.4,2.8,Undescended Testis,Biochemical Assessment,No,HPV infection,RNA CaptureSeq,2.8,Sarcomatous,Rectal,tumor_purity.txt,10,Post neo-adjuvant therapy,85,Skin biopsy,45,No,Indeterminate,Sodium Fluoride,v5.5.5,E29,ZMYM3,Metabolomic profiling,Pattern 3,Not Reported,Kidney,False,False,False,False,Unknown,Not Reported,European Molecular Biology Laboratory,2023-05-07,SCCA,3.3,PALB2 mutation,HER2 amplifications,Chromium 3' Gene Expression v3 Library,Urachus,Kidney,10,2.2,351-400 nm,Alcian_blue_stain_pancreatic_cancer,Cryosection,Every day,Tumor-Normal Pair Analysis,Pindel,Sequenza,Tumor-Normal Pairing,HER2_S310F,Circulating Tumor DNA Methylation Analysis,Sorted Cells,Direct Detect Spectrometer,500 nM,Human_rRNA_Spike.fasta,9.4,Immunohistochemistry (IHC),3 Point Scale,3+,validated,Ethical approval pending,Approved,Strelka2,Loss of heterozygosity (LOH),False,MetastasisSample1_R2.fastq.gz,MMR_deficiency_profile,Illumina HumanExome-12v1_1,0.211,1.05,SRR1098765.bam,PathoGenius77_TrialJ,Unknown,Yes,Hormone Therapy,TruSeq Amplicon Cancer Panel,OncoCapture-OC100,Illumina TruSight One Sequencing Panel,Illumina TruSight One Sequencing Panel,PacBio,SureSelect Clinical Research Exome V2,mRNA,Positive,mm^2,5.5,Not Reported,Tebentafusp,False,No,>14 mg/L,27,50,6-30 Minutes,Within 3 Months of Surgery,Prospective,J10-45,Overlapping lesion of urinary organs,Brain,Unknown,False,1978,2018,Unknown,2250000,32768,NM_004360.4,Absent,Pouch,Head and Neck,A081801,1000,500,mg/wk,270,No Necrosis,Not Reported,Unknown,Unknown,unknown,Very Good Partial Response,365,Radiation,Photodynamic therapy,11.2,anaplastic large cell lymphoma,71,No,9.0,Superficial,2.8,Xenograft,Unifocal,Unknown,Four Tier,Few,Many,9.4,0.8,Posterior horn,10,0.05,Unknown,Unknown,4.0,8.5,data_release,Unknown,Cigar,M1c,N4,Stage IVC,Tis (DCIS),cM0 (i+),Not Reported,Stage IVC,T4a,Unknown,No,Yes,60,Bilateral,Hormones,Not Reported,Bilateral,2023-10-11T15:05:00Z,9,Unknown,Translocation,Yes,Micro,Unknown,lost to follow-up,39,58.6,Capsular invasion,9,J10,Not Applicable,Unknown,GX,Unknown,2024-04-18T08:30:00Z,https://github.com/targeted-therapy/workflow10/commit/t6u7v8w9x0,2023-10-13T14:15:00,VarScan2,5.3.2,1938,2024,2014,10,35,Transition zone,Nullizygous
1.7,E17K,FAIL,PacBio_SMRTbell_Adapter,TCTTCCGATCTTAGGCATCTCCTATGTAGGC,Dysplasia; high grade,Not Reported,Diarrhea,Grade 3,16425,59,70,60,False,HER2 amplifications,Toxoplasmosis,M1,NX,Stage IIIA,Tis (DCIS),M1d,N4,Not Reported,Tis (DCIS),2nd,2.5,5.0,Weekly Drinker,Unknown,Non-Drinker,Other,control_sample_04.bam,R11_23489,11. Viral Integration Site Analysis,CLC Genomics Workbench,550,550,Ascites fluid,200.0,pharmacogenomics_results.sql,3.2,Repli-G (Qiagen) DNA,W,550,KRAS,Not Reported,Focal,Trisomy,Yes,Fever,Stage III,Yes,Stage III,IDH1_R132H,Kappa,cBioPortal for Cancer Genomics,Unknown,Crocidolite,29.9,650,325,False,No,Mutect2,Albacore_2.2.7,WARN,1111,BCR-UV11,PPD-Pseudoprogression,Fundus Of Stomach,Right,N-2 Supplement,Serum,1.25,0.8,17.0,35.4,2.61,Yes,4.0,pediatric,Surveillance,Thyroid cancer,HCMI-03132,Biospecimen identity unknown,Toxicity,Unknown,Lifestyle-related effect,350,Intravenous Drug User,50000,Molecular Oncology Center (MOC),Massachusetts General Hospital Cancer Center,Green,Diesel exhaust,Unknown,C,MethChip_011,K11-50,abcam ab4729 anti-H3K27ac,Input Control,t(10;11)(p11.2;q23),chr9,Not Reported,60,6.0,Not Reported,CenterNotification,Premalignant,Zinc,No,Clonal,No,PHAR-2023-11,Not Reported,High Risk,Stage II,Unknown,Unknown,Asthma,Ulcerative Colitis,Radiology,Derived Cell Line,5.0,Consent by Death,Not Reported,0.05,0.12,Not Reported,10,copy_number_gain_loss_map.svg,10,BreakDancer_Max,21,Chromosome Conformation Capture,Malaysia,Belize,11,2023-11-25T18:25:00Z,1615420800,Dr. Tony Hunter,350,2p21,DNA Methylation,TARGZ,MAF,Lynch syndrome,Gene Level Copy Number Scores,Patient Reported Outcomes,120,154,-9855,90,240,35,330,210,210,2190,90,2920,90,450,42,330,330,730,-4015,42,60,98,300,75,phs000434,Body Mass Index (BMI),Immune_repertoire.fasta,Acute myeloid leukemia,Not Reported,Pancreatic cancer,False,Unknown,10,TE-Too Early,Mature T- and NK-Cell Lymphomas,Unknown,DISTR-01122ML,59,10.1158/2159-8290.CD-19-0568,Not Reported,No,PARP inhibitor,No Dysplasia,Not Reported,4,High School Graduate or GED,Unknown,Lipiodol,Illumina 1.9,Unknown,Regional or Distant Metastasis (M1),Stage III,Unknown,M1,N1,Stage IV,T1,Yes,62.1,file_size,Not Reported,Not Reported,not hispanic or latino,Convincing Image Source,Convincing Image Source,5 or More Days,exon11,ethical_approval_document.pdf,Immunogenicity_LC540_Carboplatin,Allprep RNA Extraction,Cell Culture Assays,Genotyping Array,Unknown,8.0,45,Occupational,Smokeless Tobacco,Ionizing radiation,miRNA expression analysis,Extensive,Unknown,Gross Extension,False,Unknown,Amber,M5,Kidney cancer,control_group1_R1.fastq,90.3,70.3,64,103,Stage IVB,1988,ColonTumor_Sample10_microarray.tif,524288,uploaded,MutationAnalysis.maf,11,Second Malignant Neoplasm,0-30 Days,Not Reported,FCB12345H6,Post-treatment monitoring,650,700,600,43.8,MboI,Isothermal freezing,Not Reported,female,ESR1_gene_silencing,CARS,Somatic Mutation Aggregation,DRAGEN Germline Pipeline,Group 2,Pattern 4,55,12,Not Reported,10.1,25.6,132,No,165,Not Reported,Poorly differentiated,H2A,H3.1,Not Reported,Lower Grade Glioma,3.0,Unknown,Unknown,Estrogen only,51,HPV66,Bladder,Not performed,C54.1,C82.5,root,Poor Prognosis,Skin,2023-11-03,Liver Involvement,Not Performed,5.6,14.7,PET,Azathioprine,False,True,Sample Procurement,Not Reported,75.3,Unknown,Not Reported,L2,Stage 4S,454 GS FLX Titanium,2025-06-29,30.8,High-Intermediate Risk,intron-11,Group IIc,Not Reported,True,False,"3,4 - Fibrous Septa",III,20,PASS,Blast Count,11,Macroscopic (greater than 2cm),not reported,Left,2013-12-03T22:31:50Z,2022-10-07T13:00:00Z,12,RadiogenomicsArchive,Ion Plus Fragment Library Kit (4471252),TruSeq Stranded Total RNA,Sigma-Aldrich,Agilent SureSelectXT Methyl-Seq v1.0,Hybrid Selection,Second_Stranded,scRNA-Seq,10,60,BCR-ABL 22q11.23,28.9,Yes,Functional (Limited) Neck Dissection,Neck,Splenic,Unknown,10,No,10,Unknown,2500,11,7.0,Unknown,Gerota Fascia,Domestic Partnership,Stage IIb,CGI_11820_Hypomethylated,MET_D1010N,Splenic lymph nodes,9bf31c7ff062936a96d3c8bd1f8f2ff3,500X,Radiologic,Millimeters,WNT-Activated,No,Unknown,No,Not Reported,Vertebral Canal,Autopsy,Partial Maxillectomy,Cell Type Deconvolution,0.8,MethylKit Conversion Workflow,No,Unknown,11,high-throughput sequencing (HTS),hsa-miR-92a-3p,Not Reported,Not Reported,12,1600,RT-PCR,Mature miRNA Variant,BCR-ABL fusion protein,Micropapillary,8013/3,10.6,MSI,QRC369S8M,61,Class III,210,lowess_normalized_smoothed,cancer.gov,26.7,Yes,False,True,False,True,Unknown,Unknown,Statin,Yes,Adverse reactions to chemotherapy observed,1100,18,40,1500,25,Bioinformatician,OCT-Embedding-Positive,Molecular Subtype,Ovarian Capsule Ruptured,Unknown,Not Reported,Yes,Continuous,35.0,150,2019,Type 2,Lymph node biopsy,No,15,Uncertain Significance,Adenocarcinoma,h7g8f9e0-d1c2-b3a4-s5d6-f7g8h9i0j1k2,Basal cell carcinoma,Nephrectomy specimen with tumor that is present at the surgical margin of resection or within regional lymph nodes; distant metastasis identified at diagnosis,PASS,Not Reported,Not Reported,PASS,Not Reported,PASS,4.3,90.2,65,50.6,62.8,40.0,13.6,68.3,30.2,18.9,50,50,21.9,50.7,74.5,90.5,Yes,0,10,Atypical,Not Reported,ThyroidCancer_BRAF_V600E,K11,Illumina Human Methylation 450,Affymetrix CytoScan,Not Reported,35678901,P11,20-21 servings/day,10,Induced Abortion,Yes,Not Reported,550 mg,Unknown,Pseudomucinous cystadenoma,False,Pattern 1,Other and unspecified female genital organs,yes,Not Allowed To Collect,dna-seq skip,Endoscopy,Molecular Oncology Projects,Not Allowed To Collect,face and neck,Local,Colorectal Cancer Screening Innovations,COLON-CR-2023,11. Glioblastoma Multiforme Therapeutic Approaches,0.028,0.78,0.89,0.55,0.96,0.5,10,65,50,CD20,3881,white,Yes,Not Reported,Agilent SureSelect Methyl-Seq,RG011_PatientF_Tumor,Percentage of Q30 Bases,Illumina_HiSeq_X_Ten,500,Not Applicable,Disease Progression,Scheduling Problems,11,32.1,Not Applicable,Stem cell transplant,patient_questionnaires.sav,Radiology_Reports,62,male,Bladder Cancer,Unrelated,No,Yes,yes,10,True,2023-11-25,True,False,True,R2,RX,11-20 mm,Unknown,11,50,Yes,2.4,2.1,Vascular Disease,Clinical Assessment,No,Radiation exposure,Direct RNA Sequencing,2.1,Lymphoid,Sublingual,immune_repertoire.fasta,11,Primary Tumor,1,Liver biopsy,50,No,Indeterminate,Axumin,v6.0.0,E32,PHF6,Transcriptome sequencing (RNA-seq),Pattern 3,Not Reported,Thyroid,False,True,False,False,Unknown,FAIL,Johns Hopkins Genomic Core Facility,2023-07-21,BWH,6.0,PMS2 mutation,IDH1 R132H,Chromium 3' Gene Expression v3 Library,Uterine adnexa,Spleen,11,4.6,401-450 nm,Congo_red_stain_amyloidosis_associated_with_myeloma,Periodic acidSchiff,Unknown,SomaticSeq,Tumor-Normal Pairing Analysis,XHMM,HaplotypeCaller,MET_D1228N,RNA Splicing Analysis,Granulocytes,Fluorescence Spectroscopy,1 M,Drosophila_SpikeIn.fasta,51.2,Haemotoxylin and Eosin (H&E),3 Point Scale,2+,validated,Sequencing error identified,Approved,GATK-SV,Amplifications,False,TumorSample3_R1.fastq.gz,CDKN2A_loss_of_function_analysis,Agilent CGH+SNP Microarray,0.598,0.95,SRR6789012.bam,CancerCode41_ProjectK,White Matter,Yes,Stem Cell Research,TruSeq Amplicon Cancer Panel,PrimeTarget-PTK200,Ion Torrent AmpliSeq Comprehensive Cancer Panel,xGen Exome Research Panel v1.0,New England Biolabs,TruSight One Sequencing Panel,DNA,Staining Intensity Value Reported,g/dL,11.0,30-39%,Fosgemcitabine Palabenamide,True,Unknown,>14 mg/L,30,55,6-30 Minutes,Adjuvant Therapy,Retrospective,K11-50,Posterior wall of bladder,Stomach,Not Reported,True,1985,2019,6,2500000,65536,NM_001005862.3,Unknown,Popliteal Fossa,Esophagus,A081801,1200,550,mg/m2,300,Unknown,Not Reported,Once Weekly,Consolidation Therapy,unknown,Mixed Response,400,3D Conformal,Laser therapy,12.8,Rhabdoid tumor (kidney) (RT),41,No,10.5,Not Reported,3.0,Unknown,Unifocal,GX,Four Tier,Few,Many,10.5,11.3,Lateral horn,11,0.9,1,Unknown,4.5,4.3,data_release,Waste burning smoke,Electronic Cigarette,Unknown,N1,Stage IIC1,T2b,Not Reported,N0 (mol+),Stage IVC,T4a,7th,Yes,Not Reported,72,Right,Testis Removed,Yes,Left,2023-11-02T11:25:00Z,10,Unknown,Conversion,Not Reported,No Vascular Invasion,HBV DNA,lost to follow-up,40,102.3,Size > 10 cm,8,K11,10x-25x,Unknown,G2,Unfavorable,2024-05-22T15:45:00Z,https://github.com/cancer-immunotherapy/workflow11/commit/y1z2a3b4c5,2023-11-02T08:45:00,AscatNGS,6.0.0,1942,2025,2015,11,40,Transition zone,Unknown
1.65,R249S,PASS,Oxford_Nanopore_Adapter,GATCTCGTATGCCGTCTTCTGCTTGAAA,Clostridioides difficile (c. diff),Not Reported,Skin and Subcutaneous Tissue Disorders - Other,Grade 2,23725,65,75,65,True,MET amplifications,Wasting Syndrome,Unknown,NX,Stage III,T1b,cM0 (i+),N3a,Stage III,TX,6th,3.5,6.0,Weekly Drinker,Unknown,Not Reported,Wine,carcinoma_sample_05.bam,R12_34501,12. Somatic Hypermutation Correction,PAGIT,600,600,Lymph node biopsy frozen,250.0,histopathology_image_annotations.pickle,6.0,Repli-G X (Qiagen) DNA,D,600,ALK,No,Diffuse,Monosomy,Not Reported,Night Sweats,Stage IV,No,Stage IV,CDKN2A_W110*,Surface,Broad Institute's GDAC Firehose,Unknown,Amosite,31.2,700,350,False,No,VarScan2,Bonito_0.1.3,WARN,1212,BCR-WX12,PPD-Pseudoprogression,Lymph Node(s) Supraclavicular,Left,Human Serum Albumin,Urine,2.75,150.0,145.0,37.9,2.72,Yes,4.5,Unknown,Screening,Ovarian cancer,HCMI-03435,Center QC failed,Unknown,Medical Record,Metabolic change response,880,Intravenous Drug User,55000,Cancer Immunotherapy Center (CIC),Northwestern University Robert H. Lurie Comprehensive Cancer Center,Green,Silica dust,Yes,Not Reported,MethChip_012,L12-55,abcam ab4729 anti-H3K27ac,H3K9me3,t(6;11)(q27;q23),chr9,p,70,6.5,III,Observation,Synchronous primary,Flaxseed Oil,No,Clonal,Yes,CELL-2023-12,Unknown,High Risk,Stage IV,High Risk,Unknown,Hyperlipidemia,Unknown Etiology,Histology,2D Classical Conditionally Reprogrammed Cells,10.0,Consent Exemption,No,0.055,0.09,Small Bowel,11,CNV_frequency_histograms.png,11,GenomeSTRiP_svLiftover,23,Optical Genome Mapping,Malaysia,Jersey,12,2023-12-30T20:00:00Z,1615507200,Dr. Dennis Slamon,400,4q25,Sequencing Reads,TIFF,SAM,PIK3CA mutation,Clinical Supplement,Electronic Health Records,150,168,-11680,120,270,42,365,240,240,2555,120,3285,180,500,49,360,360,800,-4380,49,75,112,330,90,phs000435,Smoking Status,Single_cell_data.h5,Chronic lymphocytic leukemia,Thiazolidinedione,Kidney (Renal Cell) cancer,True,Unknown,11,WT-With Tumor,Myxomatous Neoplasms,Unknown,DISTR-01233TC,120,10.1016/j.ccell.2020.03.012,No,Yes,Glucocorticoid,Indefinite,Esophageal Columnar Dysplasia,2,High School Graduate or GED,Favorable,Lipiodol,NextSeq,Not Reported,No Metastasis (M0),Stage IA,Unknown,M1,N1,Stage I,T4,No,68.3,md5sum,Not Reported,Yes,hispanic or latino,Convincing Image Source,Convincing Image Source,3 to 4 Days,exon12,cell_line_provenance.xlsx,StemCellFrequency_K562_Nilotinib,aDNA Preparation Type,Xenograft Modeling,Reverse Phase Protein Array,Not Reported,10.0,50,Social,Coal Dust,Arsenic in drinking water,Quantitative real-time PCR (qRT-PCR) analysis,Extensive,Unknown,Gross Extension,False,Unknown,Gray,M3,Bladder cancer,control_group1_R2.fastq,62.8,77.9,107,65,Stage IC,2009,Leukemia_SubtypeB_clinical.pdf,1048576,error,SurvivalData.xlsx,12,Death,0-30 Days,Motor or Movement Changes,FCB23456I7,No evidence of disease,700,750,650,58.3,MboI,Freezing under vacuum,Not Reported,unspecified,MDM2_amplification,ROBO2,Germline Variant Phasing,Joint Genotyping Workflow,Group 1,Pattern 4,60,13,Unknown,11.5,130.2,144,No,160,No,Unknown,H3,H2A.Z.2.2,Not Reported,Lower Grade Glioma,4.0,Unknown,Current User,Not Reported,33,HPV66,Microscopic Parametrium,Simple Hysterectomy,C73,C91.0,root,Poor Prognosis,Bone,2023-12-01,Retroperitoneal Lymph Node Involvement,Negative,1.5,16.2,CT Scan,,False,True,Study Enrollment,Not Reported,80.6,Undifferentiated or Poorly Differentiated,Not Reported,L2,Stage 1,Ion Torrent PGM,2025-09-03,34.1,High-Intermediate Risk,intron-12,Group IV,Unknown,True,False,6 - Established Cirrhosis,Unknown,30,FAIL,Blast Count,12,Not Reported,Distant met recurrence/progression,Left,2012-10-20T23:13:15Z,2023-01-22T09:55:00Z,15,Chemoresistome,TruSeq Nano DNA Library Prep Kit (20015964),Clontech SMART-Seq v4,PerkinElmer,TruSeq Stranded mRNA v3,PCR,Second_Stranded,scATAC-Seq,12,70,MSH2 2p22.2,31.2,Yes,Functional (Limited) Neck Dissection,NOS,Submandibular,Indeterminant,11,Not Reported,12,Unknown,3000,12,8.0,Not Reported,Renal Vein,Married,Stage IVb,CGI_12945_Unchanged,HER2_S310F,Thyroid,70efdf2ec9b086079795c442636b55fb,550X,Echographic,Centimeters,Not Determined,Not Reported,Unknown,Unknown,Distant Metastasis,Lymph Node,Cystoscopy,Bone Marrow Aspirate,Age and Gender Adjustment,0.5,BSMAP to MethPipe Liftover,No,Not Reported,12,stem-loop RT-PCR,hsa-miR-205-5p,Not Reported,Intermediate,15,1400,Sequencing,5 Prime UTR Variant,CD20 expression,Non-cohesive,8251/3,11.4,MSI,ZXD531G9N,12,Class III,230,hg19,mayo.edu,29.9,No,False,True,False,True,Not Reported,Unknown,Metformin,No,Surgical margins clear of tumor cells,1200,20,45,1800,28,Environmental Health Officer,OCT-Embedding-Negative,Tumor Mutational Burden,Ovarian Capsule Ruptured,Unknown,Unknown,Yes,Intermittent,40.0,270,2021,Type 1,Stool sample,No,20,Uncertain Significance,Melanoma,i9h8g7f6-e5d4-c3b2-a1s0-f9e8d7c6b5a4,Squamous cell carcinoma,Nephrectomy specimen with tumor confined to the kidney; distant metastasis identified at diagnosis,Unknown,Unknown,FAIL,PASS,Not Reported,Unknown,6.9,93.7,67,55.8,18.9,45.2,5.3,75.0,33.7,12.5,55,55,4.4,60.5,79.2,92.3,Unknown,4 or More,12,Atypical,Not Reported,Hepatocellular_AFP_Screen,L12,Illumina Human Methylation 27,NanoString nCounter,Near Diploid,36789012,P12,22-23 servings/day,11,Ectopic Pregnancy,Not Reported,No,600 mg,Snap Frozen,borderline malignancy,False,Pattern 4,Other and unspecified female genital organs,Not Allowed To Collect,Not Reported,dna-seq skip,Endoscopy,Radiation Oncology Advances,Not Reported,Olfactory nerve,Biochemical,Ovarian Cancer Biomarker Identification,HEMATO-ONC-16,12. Sarcoma Genetic Research,0.03,0.94,0.88,0.6,0.86,0.55,12,70,55,MDM2,ADVL0215,white,Yes,Yes,Oxford Nanopore MinION Methylation Sequencing,RG012_PatientF_Normal,Adapter Content,Ion_Proton,550,Not Applicable,Course of Therapy Completed,Scheduling Problems,12,35.6,No Treatment,Monoclonal antibodies,laboratory_tests_results.csv,Surgical_Reports,45,unspecified,Leukemia,Foster Brother,Yes,Yes,yes,11,False,2023-12-30,True,True,True,R2,R0,1-10 mm,Unknown,12,55,Yes,1.3,1.5,Hereditary Ovarian Cancer,Clinical Assessment,Not Reported,Sun exposure,TCR Sequencing,1.5,Myeloid,Intrathecal,differential_expression.csv,12,Benign Neoplasms,6,Lung biopsy,55,No,Indeterminate,Sodium Fluoride,v6.6.6,E35,H3F3B,Chromatin accessibility assays,Pattern 3,Not Reported,Skin,True,False,True,True,WARN,FAIL,Dana-Farber Cancer Institute,2023-08-30,UPMC,1.4,STK11 mutation,NPM1 mutations,Chromium 3' Gene Expression v2 Library,Uvula,Pancreas,12,3.3,451-500 nm,Toluidine_blue_stain_mast_cell_tumor,Masson's trichrome,Every day,FACETS,HaplotypeCaller,PURPLE,FreeBayes,NRAS_Q61R,Non-Coding RNA Analysis,Granulocytes,Colorimetric Assay,2.5 M,C.elegans_miRNA_Spike.fasta,60.8,Haemotoxylin and Eosin (H&E),3 Point Scale,4+,released,Sample mix-up suspected,Approved,TIDDIT,Point mutations,False,TumorSample3_R2.fastq.gz,BCR-ABL_translocation_typing,Illumina Infinium MethylationEPIC,0.483,1.1,SRR2109876.bam,TissueMark66_ResearchL,Not Reported,Yes,Genetic Mutations,TruSeq Amplicon Cancer Panel,CaptureSelect-CS500,QIAseq Targeted DNA Human Exome Panel,NimbleGen SeqCap EZ Human Exome Library v2.0,PerkinElmer,NimbleGen SeqCap EZ MedExome,DNA,Intermediate,mm^2,6.3,1-49%,Fosgemcitabine Palabenamide,True,Not Reported,>14 mg/L,35,60,6-30 Minutes,Other,Prospective,L12-55,Rib,Esophagus,Peritumoral,False,1999,2020,Not Reported,2750000,128,ENST00000557334.5,Present,Penis,Stomach,EA5142,1400,600,mg/day,330,No Necrosis,Not Reported,Unknown,Consolidation Therapy,unknown,Mixed Response,435,Radiation,Radiofrequency ablation,14.4,Rhabdomyosarcoma,41,No,12.8,Superficial,4.2,Unknown,Unifocal,G4,Four Tier,Few,Few,11.1,10.1,Medial horn,12,0.8,Not Reported,Diffuse,5.2,9.7,data_release,Work-related smoke,Cigar,M1b,N4,Stage IA1,Tis (DCIS),M1b,N0,Stage IB1,T1c2,7th,Yes,Not Reported,84,Not Reported,Spontaneous Descent,Yes,Not Reported,2023-12-23T19:40:00Z,12,Somatic,Translocation,Not Reported,Unknown,Unknown,dead,41,110.5,Weight > 200 g,3,L12,10x-25x,Not Reported,G2,Favorable,2024-06-12T12:00:00Z,https://github.com/rna-sequencing/workflow12/commit/d6e7f8g9h0,2023-12-07T16:00:00,VarScan2,6.1.1,1946,2026,2016,12,45,Transition zone,Unknown
2.25,N345K,FAIL,Roche_454_Adapter,CAGACGTGTGCTCTTCCGATCTGATC,Diffuse and early nodular diabetic glomerulosclerosis,Not Reported,Dry Skin,Grade 1,29200,72,80,70,False,VHL mutations,Wasting Syndrome,M1,N1bIV,Stage IIIA,Ta,Unknown,N1c,Stage 0a,TX,7th,4.5,7.0,Weekly Drinker,No,Social Drinker,Liquor,lymph_node_sample_06.bam,R13_45612,13. Structural Variant Reconciliation,SMALT,650,650,Lymph node biopsy FFPE,300.0,single_cell_cluster_assignments.csv,0.3,RNA,D,650,PDL1,Unknown,Diffuse,Monosomy,Not Reported,Other,Stage IV,Unknown,Stage I,MET_D1228N,CD45,National Cancer Institute's Genomic Data Commons Data Portal,No,Amosite,38.4,750,375,True,No,Clara Parabricks,Guppy_3.1.5,PASS,1313,BCR-YZ13,PPD-Pseudoprogression,Testis,Unknown,DMSO,Granulocyte,0.25,5.0,99.0,40.2,2.83,Yes,5.0,adult,Screening,Liver cancer,HCMI-03738,Qualification metrics changed,Unknown,Death Certificate,Psychological stress impact,420,Intravenous Drug User,60000,Genomic Medicine Center (GMC),University of Michigan Rogel Cancer Center,Green,Beryllium,Not Reported,C,MethChip_013,M13-60,abcam ab4729 anti-H3K27ac,Input Control,Unknown,chr3,p,80,7.0,V,Observation,Synchronous primary,Mushroom Extracts,No,Clonal,Unknown,PATH-2023-13,Unknown,Unknown,Not Reported,High Risk,Unknown,Arthritis,Renal Failure (Requiring Dialysis),Pathology,Control Analyte,15.0,Informed Consent,No,0.06,0.11,Small Bowel,12,CNV_clinical_annotation_report.rtf,12,Lumpy_Liftover,25,RNA Sequencing,Malaysia,Guatemala,13,2024-01-15T07:40:00Z,1615593600,Dr. Angela Hartley Brodie,450,6p22.3,Sequencing Data,BEDPE,BED,HPV-positive,Splice Junction Quantification,Biochemical Data,180,182,-10220,150,300,60,400,270,270,2920,150,3650,365,550,56,400,390,900,-4745,56,90,126,365,120,phs000436,Alcohol Consumption,Pharmacogenomics_data.csv,Glioblastoma multiforme,Not Reported,Glioblastoma,False,Not Reported,12,WT-With Tumor,NOS,Adjacent (< or = 2cm),DISTR-01344RC,81,10.1084/jem.20191865,No,No,PARP inhibitor,Indefinite,Esophageal Mucosa Columnar Dysplasia,5,Vocational College or Some College,Unknown,Y-90 Sirsphere,TwoColor,Not Reported,Not Reported,Unknown,Unknown,M0,N1,Stage II,T4,Yes,74.9,file_size,Indefinite for Dysplasia,Not Reported,hispanic or latino,Convincing Image Source,Histologic Confirmation,5 or More Days,exon13,treatment_dosage_calculation_methods.txt,ChromatinAccessibility_HeLa_DMSO,Repli-G X,CRISPR-Cas9 Gene Editing,Total RNA-Seq,Six Weeks or More,12.0,55,Occupational,Smoke,Benzene,Mass spectrometry data analysis,Extensive,Unknown,Gross Extension,True,,Brown,M5,Stomach cancer,experiment_group2_R1.fastq,77.4,83.7,78,79,Stage IA,2009,OvarianCancer_Patient11_Proteomics.dat,2097152,validated,Immunohistochemistry_Images.zip,13,,31-90 Days,Motor or Movement Changes,FCB34567J8,Progressive disease,750,800,700,46.5,MboI,Slush nitrogen freezing,Not Reported,female,FLT3_internal_tandem_duplications,BMP5,Multi-Omics Data Integration,Octopus,Group 4,Pattern 4,65,14,No,12.7,90.0,156,No,173,Not Reported,Anaplastic,Unknown,CENP-A,No,Phenochromocytoma or Paraganglioma,5.0,Unknown,Unknown,Estrogen only,53,HPV18,,Not performed,C82.9,C73,root,Good Prognosis,Stomach,2024-01-20,Liver Involvement,Negative,3.9,18.5,PET,,True,True,Initial Genomic Sequencing,Unknown,85.1,Differentiating,Unfavorable,L1,Stage 2B,Illumina Genome Analyzer IIx,2025-11-17,37.3,Low Risk,intron-13,Group IV,3,True,False,6 - Established Cirrhosis,Unknown,30,PASS,Blast Count,13,Unknown,Biochemical evidence of disease without structural correlate,Bilateral,2011-08-06T01:54:30Z,2021-05-13T18:10:00Z,20,TumorMicroenvCatalog,Lexogen QuantSeq 3' mRNA-Seq Library Prep Kit (015.96),Nextera DNA Flex,10x Genomics,Ribo-Zero Gold Kit v1.2,rRNA Depletion,Second_Stranded,m6A MeRIP-Seq,15,80,VHL 3p25.3,33.7,Yes,Functional (Limited) Neck Dissection,NOS,Supraclavicular,Negative,12,Not Reported,15,Unknown,4000,13,9.0,Indeterminant,Renal Vein,Divorced,Stage IIa,CGI_14010_Hypermethylated,IDH1_R132H,Maxilla,98f13708210194c475687be6106a3b84,600X,Radiologic,Centimeters,Not Determined,Not Reported,Perimenopausal,Unknown,Unknown,Ascites,Autopsy,Subtotal Prostatectomy,Sample Quality Assessment,0.95,EpicArray to WGBS Conversion,Not Reported,Unknown,13,microRNA pull-down assay,hsa-miR-200c-3p,Yes,Intermediate,20,2400,NOS,5 Prime UTR Variant,FLT3 mutations,Solid,8013/3,12.8,MSI,VBR682J0Q,61,Class III,255,Paired_LogR,cshl.edu,33.3,Yes,True,True,False,False,Not Reported,Unknown,Statin,Not Reported,Resistance to targeted therapy developed,1300,24,50,2100,30,Health Services Manager,Confirmed-OCT-Embedding,Oncotype DX Score,Unknown,Unknown,WARN,Yes,Intermittent,45.0,360,2022,Type 1,Fine needle aspirate,No,25,Uncertain Significance,Glioblastoma,j1k2l3m4-n5o6-p7q8-r9s0-t1u2v3w4x5y6,Osteosarcoma,Nephrectomy specimen with tumor confined to the kidney; distant metastasis identified at diagnosis,PASS,FAIL,Not Reported,Unknown,Not Reported,FAIL,13.7,97.5,70,60.3,47.1,48.6,10.2,82.5,37.9,7.2,60,60,29.7,70.2,85.0,94.7,Unknown,Not Reported,14,Atypical,Not Reported,CervicalCancer_HPV_Typing,M13,RPPA,Illumina NextSeq,Not Reported,37890123,P13,24-25 servings/day,12,Ectopic Pregnancy,Yes,Not Reported,650 mg,Not Allowed To Collect,Recklinghausen disease,True,Pattern 3,Anus and anal canal,yes,Not Allowed To Collect,dna-seq skip,Unknown,Surgical Oncology Techniques,No,Overlapping lesion of digestive system,Locoregional,Bladder Cancer Treatment Optimization,SARCOMA-2022-RE,13. Hepatocellular Carcinoma Surveillance Programs,0.033,0.99,0.87,0.65,0.97,0.6,15,75,60,BCL-2,AALL0031,not allowed to collect,No,No,PacBio SMRT Sequencing for Methylation,RG013_PatientG_Tumor,Sequencing Platform,PacBio_Sequel_II,600,R3,Death,Scheduling Problems,13,39.8,Unknown,Combination therapy,radiomics_features.mat,Immunohistochemistry_Results,29,female,Wilms Tumor,Sibling,No,Not Reported,not reported,12,False,2024-01-15,True,False,False,Not Reported,R1,11-20 mm,No,13,60,No,2.5,1.9,Vascular Disease,Clinical Assessment,No,Hormone replacement therapy,RNA Microarray,1.0,Carcinomatous,Intraarterial,protein_abundance.txt,13,Bone Marrow Normal,17,Breast tissue,60,No,Not Reported,Choline,v7.0.3,E38,PHF6,Proteogenomics,Pattern 3,Not Reported,Ovary,False,True,False,False,FAIL,Not Reported,The Francis Crick Institute,2023-10-12,CSHL,2.2,CDH1 mutation,FLT3 internal tandem duplications,Chromium 3' Gene Expression v3 Library,Supraglottis,Ovary,13,5.9,501-550 nm,Mucicarmine_stain_adenocarcinoma,Silver stain,Some days,PureCN,SomaticSeq,Allele-Specific Copy number Analysis of Tumors (ASCAT),Manta,CDKN2A_W110*,Digital PCR for Rare Mutation Detection,Mixed Adherent Suspension,SpectraMax,5 M,Bovine_Serum_Albumin.fasta,18.5,Haemotoxylin and Eosin (H&E),3 Point Scale,0,processed,Contamination with foreign DNA,Approved,WHAM,Chromothripsis,True,NormalSample3_R1.fastq.gz,MET_exon_14_skipping_variants,Affymetrix Axiom Genome-Wide PanAFR Array,0.369,0.8,SRR7890123.bam,BioMarker53_StudyM,Thalamus),Yes,Apoptosis,Custom SureSelect Human All Exon v1.1 Plus 3 Boosters,TargetGen-TGK850,NEBNext Direct Cancer HotSpot Panel,Agilent SureSelect Focused Exome,Bio-Rad Laboratories,Agilent SureSelect Human All Exon V8,Total RNA,Normal,mg/dL,12.8,Not Reported,Fc-engineered Anti-CD40 Agonist Antibody 2141-V11,True,Not Reported,>14 mg/L,40,90,Unknown,Adjuvant Therapy,Prospective,M13-60,sternum,Thyroid,Tumor,False,1968,2021,2,3000000,256,NM_000314.6,Present,Pouch,Bladder,E4512,1600,650,mg/m2,365,Unknown,Not Reported,Unknown,Unknown,unknown,Treatment Stopped Due to Toxicity,470,Radioisotope,Proton therapy,16.0,Soft tissue sarcoma,41,No,14.3,Superficial,5.6,Unknown,Unifocal,Low Grade,Three Tier,Few,Many,12.6,12.6,Superior aspect,13,0.7,Not Reported,Diffuse,6.0,1.8,data_release,artificial smoke machines,Other,M1a,N1mi,Stage IVB,T0,M1,Not Reported,Stage IB1,Not Reported,2nd,Yes,Yes,96,Bilateral,Spontaneous Descent,Not Reported,Bilateral,2024-01-07T20:15:00Z,15,Unknown,Inversion,Not Reported,Intramural,HBV DNA,lost to follow-up,42,49.9,Increased mitotic rate,8,M13,10x-25x,Not Reported,GX,Unknown,2024-07-27T20:15:00Z,https://github.com/protein-analysis/workflow13/commit/i1j2k3l4m5,2023-01-28T10:30:00,BCGSC miRNA Profiling,7.0.0,1950,2027,2017,13,50,Overlapping/multiple zones,Homozygous
1.6,G13C,FAIL,Mega_RAP_Adapter,TCGTATGCCGTCTTCTGCTTGATCG,Dysplasia; high grade,Yes,Skin and Subcutaneous Tissue Disorders - Other,Grade 3,32850,78,85,75,False,NF1 mutations,Cytomegalovirus,M1b,N1a,Stage IB2,Tis (DCIS),M1a,N1c,Not Reported,T2a1,3rd,5.5,8.0,Weekly Drinker,no,Lifelong Non-Drinker,Liquor,patientC_tumor_rep3.bam,R14_56723,14. Single-Nucleotide Variant Normalization,Velvet,700,700,Stool,400.0,radiomics_feature_set.xls,5.5,RNA,R,700,LDH,No,Diffuse,Trisomy,Not Reported,Other,Stage III,Unknown,Stage III,FLT3_ITD,CD33,COSMIC (Catalogue of Somatic Mutations in Cancer),Unknown,Amosite,24.1,800,400,True,No,SomaticSniper,Albacore_1.0.0,PASS,1414,BCR-XY14,IPD-Immunoprogression,Bladder,Right,ROCK Inhibitor Y-27632,Bone Marrow,4.0,7.35,32.0,23.6,2.94,Yes,5.5,Sporadic,Surveillance,Cervical cancer,HCMI-04041,Center QC failed,Unknown,Not Reported,Nutritional factor response,260,Transfusion Recipient,65000,Radiation Oncology Center (ROC),City of Hope Comprehensive Cancer Center,Green,Ethylene oxide,Unknown,Not Reported,MethChip_014,N14-65,abcam ab4729 anti-H3K27ac,Input Control,Unknown,chr3,q,90,7.5,III,Observation,other,Resveratrol,No,Clonal,Yes,RAD-2023-14,Stage II,Low Risk,Unknown,High Risk,Unknown,Stroke,Ulcerative Colitis,Not Reported,Control Analyte,20.0,Consent Exemption,Not Reported,0.065,0.13,Spleen,13,copy_number_event_logbook.odt,13,TITAN_CNA_Liftover,27,CRISPR-Cas9 Screening,Federated States of Micronesia,France,14,2024-02-20T22:15:00Z,1615680000,Prof. Brian Druker,500,8q24.3,Simple Nucleotide Variation,ADF,GFF,AML with FLT3-ITD,Clinical Supplement,Cell Morphology Data,210,196,-12410,180,330,90,435,300,300,3285,180,4015,730,600,63,430,420,1000,-5110,63,105,140,400,150,phs000437,Physical Activity Level,Metabolomics_data.csv,Renal cell carcinoma,Linagliptin,Cervical cancer,True,Yes,13,WT-With Tumor,Mature B-Cell Lymphomas,Not Reported,DISTR-01455EC,70,10.1038/s41388-020-1274-6,Not Reported,No,PARP inhibitor,Unknown,Keratinizing,Unknown,Professional or Graduate Degree,Favorable,PVA Particles,PacBio,Not Reported,Not Reported,Unknown,Unknown,M1,N1,Stage IV,T2,No,80.5,file_size,Not Reported,Not Reported,unknown,Convincing Image Source,Convincing Image Source,3 to 4 Days,exon14,sample_preparation_guidelines.docx,Autophagy_MDA231_Chloroquine,Repli-G X,Single-cell Sequencing,Methylation Array,Unknown,14.0,60,Occupational,Respirable Crystalline Silica,Helicobacter pylori infection,Epigenetic modification analysis,Extensive,No,No Extranodal Extension,False,,Hazel,Not Classified,Liver cancer,experiment_group2_R2.fastq,69.7,65.4,99,54,Stage IA,1988,SkinCancer_Sample12_mRNA.gff,4194304,validated,PharmacogenomicsData.csv,14,,31-90 Days,Not Reported,FCB45678K9,Stable disease,800,850,750,51.7,MboI,Methanol bath freezing,Unknown,male,ALK_rearrangement,RECQL4,Transcriptome Assembly Reconstruction,SAMtools mpileup,Group 4,Pattern 4,70,15,Not Reported,13.9,55.4,168,Not Reported,180,Not Reported,Unknown,Unknown,Unknown,No,Lower Grade Glioma,7.5,Progestin and Estrogen,Never Used,Not Reported,51,HPV66,Macroscopic Parametrium,Hysterectomy,C91.0,C43.9,root,Unknown,Bladder,2024-02-17,Carcinomatosis,Unknown,6.3,20.1,CT Scan,Cyclophosphamide,True,False,Initial Genomic Sequencing,Not Reported,90.4,Differentiating,Unfavorable,Not Reported,Unknown,Illumina HiSeq X Ten,2026-01-20,40.6,High-Intermediate Risk,intron-14,Group IIc,4,True,False,"3,4 - Fibrous Septa",Not Reported,30,PASS,Serum Mesothelin,14,Not Reported,not reported,Bilateral,2010-05-22T03:35:45Z,2022-07-19T20:35:00Z,25,OncobiomeDatabase,Clontech SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing (634888),Agilent SureSelectXT2,Zymo Research,QIAseq DNAseq v4 Kit,Hybrid Selection,Second_Stranded,WXS,20,90,FLT3 13q12.2,36.5,Unknown,Radical Neck Dissection,NOS,Pelvis,Indeterminant,13,No,20,No,5000,14,10.0,Unknown,Gerota Fascia,Married,Stage IIb,CGI_15175_Hypomethylated,NPM1_W288*,ligaments,3c59dc048e8850243be8079a5c74d079,650X,Radiologic,Centimeters,Not Determined,Not Reported,Postmenopausal,Yes,Unknown,Lung,Laparoscopy,Bone Marrow Aspirate,Data Imputation for Missing Values,0.4,Methylation EPIC to hg38 Liftover,Not Reported,Not Reported,14,FirePlex miRNA Assay,hsa-miR-141-3p,Not Reported,Not Reported,25,1300,Microsatellite Analysis,5 Prime UTR Variant,IDH1/2 mutation analysis,Solid,8013/3,13.5,MSI,NMB974K1R,13,Class V,280,LOH,icr.ac.uk,36.1,Yes,True,False,True,True,Unknown,Not Reported,Aspirin,Not Reported,Patient under palliative care only,1400,30,55,2400,35,Occupational Therapist,Denied-OCT-Embedding,BRCA1/BRCA2 Mutation Status,Unknown,Not Reported,FAIL,Unknown,Intermittent,50.0,420,2023,Type 1,Surgical resection tissue,Not Reported,30,Uncertain Significance,Osteosarcoma,k5l4m3n2-o1p0-q9r8-s7t6-u5v4w3x2y1z0,Glioblastoma,Nephrectomy specimen with tumor that is present at the surgical margin of resection or within regional lymph nodes; no distant metastasis,PASS,PASS,Unknown,PASS,FAIL,Not Reported,1.8,99.1,72,65.7,5.6,52.1,14.8,90.0,40.5,4.8,65,65,36.2,80.0,90.8,97.5,Unknown,0,16,Atypical,Not Reported,Myeloma_IgH_Clone,N14,Affymetrix SNP 6.0,BD FACSymphony,Hyperdiploid,38901234,P14,26-27 servings/day,13,Ectopic Pregnancy,Yes,Not Reported,700 mg,Not Allowed To Collect,Wolffian duct adenoma,True,Pattern 4,Skin,no,Unknown,dna-seq skip,Not Reported,Cancer Survivorship Programs,no,Parametrium,Biochemical,Sarcoma Genetic Profiling,THYROID-RES-15,14. Thyroid Cancer Diagnostic Tools,0.035,0.88,0.86,0.7,0.84,0.65,18,80,75,MET,8605,Unknown,Unknown,No,Bio-Rad Droplet Digital PCR for Methylation Analysis,RG014_PatientG_Normal,Library Strategy,Illumina_iSeq_100,650,R1,Adverse Event,Scheduling Problems,14,43.2,Not Applicable,Salvage therapy,immune_response_data.xml,Chemotherapy_Outcomes,53,unspecified,Leukemia,Maternal Great Aunt,No,Yes,yes,13,False,2024-02-20,True,True,False,R0,R1,1-10 mm,Yes,14,65,No,1.2,7.8,Vascular Disease,Clinical Assessment,Unknown,Genetic mutations,Branched DNA Amplification,0.5,Melanocytic,Intracardiac,SNP_array.aff,14,Pleural Effusion,12,Lymph node biopsy,65,No,Present,Sodium Fluoride,v7.7.7,E41,KCNJ5,Alternative splicing analysis,Pattern 1,No,Cervix,True,False,True,False,FAIL,FAIL,Cold Spring Harbor Laboratory,2023-11-05,LCI,4.7,NF1 mutation,VHL inactivation,Chromium 3' Gene Expression v2 Library,NOS,Bladder,14,1.4,551-600 nm,Fontana-Masson_stain_melanoma,Acridine orange,Some days,MSIsensor,DeepVariant,PyClone,DELLY,FLT3_ITD,Phosphoproteomics Profiling,Solid Tissue,DU 800 Spectrophotometer,10 M,Synthetic_Oligos.fasta,27.7,Haemotoxylin and Eosin (H&E),4 Point Scale,2+,processed,Delay in sample transportation,Approved,MoChA,Chromoplexy,True,NormalSample3_R2.fastq.gz,VHL_gene_mutation_assessment,Illumina HiSeq X Ten,0.822,1.25,SRR3210987.bam,CellSignal11_TrialN,Unknown,Yes,Autophagy,Custom MSK IMPACT Panel - 468 Genes,PureCapture-PCX500,IDT xGen Exome Research Panel,Ion Torrent AmpliSeq Comprehensive Cancer Panel,Sigma-Aldrich,Nextera Flex for Enrichment,DNA,Staining Intensity Value Reported,cells/mL,0.5,0-25,Fosgemcitabine Palabenamide,False,No,>14 mg/L,45,120,31-60 Minutes,Adjuvant Therapy,Retrospective,N14-65,clavicle and associated joints,Bladder,Abnormal,False,2008,2022,Not Reported,3250000,49152,NM_001256849.2,Present,Pouch,Kidney,A081801,1800,700,mg/mL,400,Unknown,Not Reported,Once Weekly,Consolidation Therapy,unknown,Treatment Stopped Due to Toxicity,500,Radiosensitizing Agent,CAR T-cell therapy,18.5,non-rhabdomyosarcoma,41,No,15.7,Superficial,8.4,Premalignant,Unifocal,GX,Four Tier,Moderate,Few,13.8,14.2,Inferior aspect,14,0.6,1,Unknown,7.3,3.3,data_release,Work-related smoke,Cigar,Not Reported,N1mi,Stage IA3,Tis (DCIS),M1b,N1bI,Stage IB1,Not Reported,7th,No,Yes,108,Right,Not Reported,No,Bilateral,2024-02-17T14:55:00Z,20,Somatic,Deletion,Not Reported,Macro,HBV Genotype,Not Reported,43,73.2,Loss of reticulin framework,8,N14,Unknown,Grade II,Not Reported,Unfavorable,2024-08-09T09:00:00Z,https://github.com/cell-signaling/workflow14/commit/n6o7p8q9r0,2023-02-15T15:45:00,BCGSC miRNA Profiling,7.4.5,1954,2028,2018,14,55,Overlapping/multiple zones,Hemizygous
2.3,P13L,FAIL,SureSelectXT_Adapter,AGACGTGTGCTCTTCCGATCATGCA,Dysplasia; high grade,No,Generalized Muscle Weakness,Grade 4,36500,85,90,80,True,IDH1 mutations,NOS,Unknown,N1bIV,Stage III,T1b,M1d,N1bII,Not Reported,T2,7th,6.5,10.0,Daily Drinker,Yes,Heavy Drinker,Liquor,patientC_normal_rep3.bam,R15_67834,15. Indel Realignment,MUMmer,750,750,Fine needle aspirate (FNA),500.0,immune_repertoire_sequences.fasta,7.2,FFPE RNA,R,750,CA 19-9,Yes,Diffuse,Trisomy,Not Reported,Fever,Stage III,Not Reported,Stage II,NPM1_W288fs,CD7,TARGET (Therapeutically Applicable Research to Generate Effective Treatments),No,Amosite,33.7,850,425,True,No,Platypus,Bonito_0.3.1,PASS,1515,BCR-ZA15,PPD-Pseudoprogression,Back,Left,Hydrocortisone,Bone Marrow,6.0,97.0,450.0,25.8,3.05,Not Reported,6.0,Sporadic,Surveillance,Esophageal cancer,HCMI-04344,Center QC failed,NOS,Unknown,Microbiome influence,590,,70000,Surgical Oncology Center (SOC),Vanderbilt-Ingram Cancer Center,Red,Acrylamide,Not Reported,C,MethChip_015,O15-70,abcam ab4729 anti-H3K27ac,H3K9me3,t(9;11)(p22;q23),chr11,p,100,8.0,V,Observation,Prior primary,Magnesium,Not Reported,Clonal,Yes,SURG-2023-15,Stage IV,Not Reported,Stage I,Intermediate Risk,Yes,Dementia,Chronic Pancreatitis,Unknown,2D Classical Conditionally Reprogrammed Cells,25.0,Consent by Death,Not Reported,0.07,0.14,Not Reported,14,CNV_pathway_analysis_results.mdb,14,Sequenza_Liftover,29,Bioinformatics Pipeline for CNV Detection,China,Guam,15,2024-03-05T05:55:00Z,1615766400,Dr. Gordon Freeman,550,12p13.2,Sequencing Data,BEDPE,Parquet,CLL with del(17p),Clinical Supplement,Environmental Exposure Data,240,210,-6575,210,365,120,470,365,365,-30,210,4380,32872,730,70,460,450,1100,-5475,70,120,154,435,180,phs000438,Dietary Habits,Transcriptome_assembly.fasta,Bladder transitional cell carcinoma,Unknown,Esophageal cancer,True,Unknown,14,PR-Partial Response,Mature T- and NK-Cell Lymphomas,Adjacent (< or = 2cm),DISTR-01566HC,105,10.1172/JCI129448,No,Yes,Glucocorticoid,Indefinite,Esophageal Mucosa Columnar Dysplasia,3,Not Reported,Intermediate,Lipiodol,Oxford Nanopore,Not Reported,Unknown,Stage IA,Unknown,M1,N1,Stage II,T4,No,87.2,file_size,Not Reported,Not Reported,not allowed to collect,Convincing Image Source,Histologic Confirmation,5 or More Days,exon15,post_experiment_outcome_measures.pdf,Senescence_BJ_Fibroblast_TGFalpha,Chemical Lysis DNA Extraction,Pharmacogenomics,Reverse Phase Protein Array,Unknown,16.0,65,Occupational,NOS,Formaldehyde,Transcriptome assembly and annotation,Extensive,No,Gross Extension,False,Unknown,Red & Violet,M3,Uterine cancer,biopsy_sampleC_R1_001.fastq,83.6,79.6,85,96,Stage IIIB,2009,PancreaticTumor_P13_SNP.h5,8388608,error,CellLine_Genotyping.txt,15,,0-30 Days,Not Reported,FCB56789L0,Palliative care consultation,850,900,800,39.4,MboI,Dry ice freezing,Not Reported,not reported,NPM1_mutations,CLTCL1,Epigenetic Modification Mapping,Canvas,Group 2,Pattern 4,75,16,Yes,15.3,40.7,180,Not Reported,190,Not Reported,Unknown,H3,H3.X,Not Reported,Phenochromocytoma or Paraganglioma,10.0,Unknown,Current User,Estrogen only,Other,HPV66,Bladder,Hysterectomy,C43.9,C54.1,root,Poor Prognosis,Cervix,2024-03-12,Retroperitoneal Lymph Node Involvement,Negative,7.1,22.4,PET,Methotrexate,True,True,Diagnosis,Residual Disease,95.7,Not Reported,Unknown,L2,Stage 3,Ion Torrent PGM,2026-03-15,43.8,Low Risk,intron-15,Group IV,4,True,False,"1,2 - Portal Fibrosis",Unknown,30,WARN,Promyelocytes,15,Macroscopic (greater than 2cm),Unknown tumor status,Unknown,2009-03-09T05:17:00Z,2023-02-15T07:40:00Z,30,PrecisionOncolibrary,Twist Human Core Exome Kit (101031).,Twist Bioscience Human Core Exome,Promega,SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing,Hybrid Selection,Second_Stranded,Targeted Sequencing,25,100,ESR1 6q25.1,39.8,Yes,Modified Radical Neck Dissection,NOS,Iliac,Indeterminant,14,No,25,No,6000,15,15.0,Indeterminant,Renal Sinus,Separated,Stage IVa,CGI_16340_Unchanged,FLT3_ITD,Parotid gland,1f0e3dad99908345f7439f8ffabdffc4,700X,Pathologic,Centimeters,Unknown,No,Unknown,Unknown,Unknown,Spinal Cord,Autopsy,Partial Maxillectomy,Technical Variation Minimization,0.65,Methyl-Seq Cross-Platform Normalization,Not Reported,Absent,15,miRNA capture sequencing,hsa-miR-29c-3p,Not Reported,Low,30,1100,Not Reported,Coding Sequence Variant,MGMT promoter methylation,Papillary,8405/0,14.9,MSI,HGT258L2S,12,Class V,305,exon,gustaveroussy.fr,39.5,Not Reported,True,True,True,False,Not Reported,Not Reported,Aspirin,Unknown,Significant lifestyle changes adopted post-diagnosis.,1500,36,60,2750,40,Dietitian,OCT-Embedding-Unknown,TP53 Mutation Status,Unknown,Indeterminate,FAIL,Yes,Continuous,60.0,30,2024,Type 1,Buccal swab,No,35,Uncertain Significance,Leiomyosarcoma,l6m7n8o9-p0q1-r2s3-t4u5-v6w7x8y9z0a1,Leukemia,Nephrectomy specimen with tumor that penetrates the renal capsule or involves the renal sinus with negative margins and negative lymph nodes; no distant metastasis,FAIL,Unknown,Unknown,PASS,FAIL,FAIL,10.2,100.0,75,70.9,70.4,55.5,1.9,97.8,45.0,1.3,70,70,11.0,90.8,97.3,99.1,No,1-3,18,Atypical,Not Reported,Sarcoma_P53_Mutation_Test,O15,Affymetrix SNP 6.0,Thermo Fisher QuantStudio,Tetraploid,39012345,P15,28+ servings/day,14,Not Reported,Yes,Not Reported,750 mg,Fresh,Recklinghausen disease,False,Pattern 4,Anus and anal canal,yes,Yes,dna-seq skip,Endoscopy,Nutrition and Cancer Recovery,Yes,Connective,Not Reported,Thyroid Cancer Pathway Analysis,OVARIAN-2023-PR,15. Metastasis Mechanisms in Renal Cell Carcinoma.,0.038,0.96,0.85,0.75,0.98,0.7,20,85,90,VEGF,9340,white,Yes,Not Reported,Qiagen PyroMark Q24 for CpG Methylation,RG015_PatientH_Tumor,Read Pair Orientation,Oxford_Nanopore_PromethION,700,R1,Death,Scheduling Problems,15,46.5,H2 Blockers,Experimental therapy,epidemiological_data.mdb,Radiation_Therapy_Summaries,70,male,Leukemia,Sibling,Yes,Yes,unknown,14,True,2024-03-05,True,True,False,R2,R0,1-10 mm,Unknown,15,70,No,1.1,9.2,Autoimmune Atrophic Chronic Gastritis,Both Clinical and Biochemical Assessments,No,Immunosuppression,Multiplexed Error-Robust Fluorescence in Situ Hybridization (MERFISH),0.2,Neuroectodermal,Nasal,microbiome_analysis.fasta,15,Post neo-adjuvant therapy,6,Fine needle aspirate,70,No,Absent,Choline,v8.0.0,E44,FES,Mutation burden analysis,Pattern 4,No,Brain,True,True,False,False,Not Reported,FAIL,HudsonAlpha Institute for Biotechnology,2023-12-20,VCCC,0.7,RB1 mutation,BCR-ABL fusion,Chromium 3' Gene Expression v3 Library,Transverse colon,Thyroid,15,7.0,>600 nm,Orcein_stain_hepatocellular_carcinoma,Wright's stain,Every day,HaplotypeCaller,Platypus,SCHISM,GRIDSS,JAK2_V617F,Tissue Microarrays Analysis,3D Organoid,Epoch Microplate Spectrophotometer,20 M,Custom_Gene_Fragments.fasta,43.9,Haemotoxylin and Eosin (H&E),4 Point Scale,3+,validated,Incorrect data entry detected,Approved,FusionCatcher,Ring chromosomes,True,MetastasisSample2_R1.fastq.gz,IDH1_R132H_mutation_detection,Thermo Fisher QuantStudio 3D Digital PCR,0.945,0.9,SRR8901234.bam,ImmunoPath22_ProjectO,Spinal Cord,Not Reported,Cell Cycle Dysregulation,Custom GENIE-DFCI Oncopanel - 447 Genes,SeqTarget-ST100,ArcherDX VariantPlex Solid Tumor,TruSeq Custom Enrichment Kit,GenScript,Ion Torrent AmpliSeq HD Custom Panels,miRNA,High,g/dL,10.4,1-49%,Tebentafusp,False,No,>14 mg/L,50,180,Within 5 Minutes,Within 3 Months of Surgery,Prospective,O15-70,Anus,Cervix,Peritumoral,True,1980,2023,Current Smoker,3500000,98304,NM_017617.3,Absent,Lymph Node(s) Occipital,Bone,E4512,2000,750,mg/day,430,No Known Treatment Effect,Not Reported,Once Weekly,Unknown,unknown,Complete Response,530,Stem Cell Transplantation,Biologic therapy,20.7,Wilms tumor (WT),1,Not Reported,11.2,Superficial,9.1,Primary,Unifocal,GX,Four Tier,Moderate,Few,15.0,15.8,Parietal lobe,15,0.5,1,Diffuse,8.1,10.4,data_release,plastics factory,Other,M1b,N1bIV,Stage IA1,T0,M1b,N2c,Stage IB,T0,6th,Yes,Yes,120,Right,Testis Removed,Yes,Left,2024-03-09T09:45:00Z,25,Unknown,Insertion,Not Reported,Extramural,HBV DNA,alive,44,67.8,Cellular monotony,8,O15,0x-10x,Grade II,GX,Not Reported,2024-09-03T17:30:00Z,https://github.com/mutation-analysis/workflow15/commit/s1t2u3v4w5`,2023-03-23T12:30:00,HTSeq - Counts,8.0.0,1958,2029,2019,15,unknown,Transition zone,Nullizygous
